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Proteins exist in equilibrium between the native (N) and the denatured (D) states. In order to 
form the biologically active native state, the amino acid sequence has to fold to form a stable 
three-dimensional structure. The large scientific community of biochemists and biophysicists 
has not yet been able to gain a complete understanding of this process. In this study, the 
unfolding of the homodimeric detoxification enzyme hGST M1a-1a (WT dimer) was 
investigated. Additionally, an F56S/R81A double-mutant (mutant monomer) was engineered 
to create a monomeric form of the protein. The mutant monomer was used to gain a better 
understanding of the unfolding events occurring at the subunit level, in the absence of 
quaternary interactions. Data from various techniques indicate the mutant monomer to closely 
resemble the tertiary structure of the subunits in the WT homodimer, making it a suitable 
model to study the unfolding mechanism of hGST M1a in the absence of quaternary 
interactions. A four-state equilibrium unfolding mechanism, involving two stable 
intermediate species, is proposed. HDX-MS studies indicate that disruption of the conserved 
lock-and-key motif, as well as the structures surrounding the mu loop, results in a 
destabilisation of domain 1. However, dimer dissociation cannot occur until the mixed charge 
cluster at the dimer interface has been destabilised. The destabilisation of domain 1 results in 
destabilisation of α4 and α5 in domain 2, because the domains unfold in a concerted manner. 
hGST M1a-1a dissociates to form monomeric intermediate (M), with weak interdomain 
interactions and compromised short-range contacts. The unstable M intermediate  
self-associates to form an oligomeric intermediate (I). The destabilisation of α6 and α7 in the 
hydrophobic core of domain 2 drives the formation of the partially structured denatured state. 
Further investigation will need to be pursued to determine whether hGST M1a-1a unfolds via 
transient intermediate states; however, the elucidation of the equilibrium unfolding pathway 
of a complex homodimeric protein is a valuable addition to the ever-growing knowledge base 
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Chapter 1: Introduction 
The chemical reactions that form the basis of life are governed by proteins, the most diverse 
and versatile molecules found within living systems. Proteins are also used in numerous 
biomedical, agricultural, industrial and environmental applications. However, the vast 
majority of systems that utilise proteins rely on the three-dimensional folded, functional state 
of the protein.  
Major uncertainties exist in understanding the complex structural rearrangement of the 
primary amino acid sequence that results in the formations of secondary, tertiary and 
quaternary structural elements, to form well-defined and functional structures. Additionally, 
the majority of protein folding studies have been conducted on small monomeric proteins, 
and not on multidomain proteins. Although the study of simpler monomeric proteins has been 
of great practical value, 80% of the eukaryotic proteome is composed of multidomain 
proteins. Elucidation of  the processes that govern multidomain protein folding will not only 
enable researchers to gain an understanding of the vast majority of biological processes, but 
will also provide insights into many disease states (Chiti and Dobson, 2006; de Oliveira and 
Silva, 2017; Ferguson and Fersht, 2003; Hartl, 2010).  
1.1. Multidomain protein assemblies 
Multidomain proteins control the regulation of several highly specific biochemical reactions 
within the cells of all living organisms (Kumar et al., 2017; McCammon, 1998; Vogel et al., 
2004). Complex multidomain structures are formed through the extensive rearrangement and 
duplication of individual domains (Han et al., 2007). Oligomerisation of these evolved 
multidomain structures not only enhances catalytic properties through the evolution of novel 
functions, but also provides an additional mechanism for stabilisation by shielding 
unfavourable hydrophobic surfaces from solvent (Ali and Imperiali, 2005; Dautant et al., 
2017; Janin et al., 1988).  
Multidomain dimeric proteins may be classified either as homodimeric or heterodimeric, with 
either heterologous or isologous subunit interface organisation (Monod et al., 1965; Nooren 
and Thornton, 2003). Heterologous interfaces consist of interacting subunits that display  
non-identical surfaces, whereas isologous interfaces consist of two identical interacting 
subunits and can, therefore, only occur in dimeric complexes (Mosca et al., 2014; Nooren and 
Thornton, 2003). Furthermore, oligomeric assemblies may be obligate complexes. Or non-
obligate complexes (Nooren and Thornton, 2003). Obligate complexes, like the interleukin 5 
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cytokine dimer (Acuner Ozbabacan et al., 2011), are permanent associations that require the 
association of subunits to function (Nooren and Thornton, 2003). On the other hand, non-
obligate complexes are composed of stable, independently functioning interacting partners 
with either permanent (e.g. an enzyme-inhibitor complex) or transient associations (e.g. 
heterotrimeric G protein) (Jones and Thornton, 1996; Nooren and Thornton, 2003).    
Oligomeric assemblies show an increase in the stability of individual subunit tertiary 
structures, as well as novel structural and functional elements. The evolution of novel 
elements occurs as a result of protein-protein interactions that are present both between and 
within oligomers. Protein interactions are precise and highly evolved networks that contribute 
towards the complexity of protein systems (Goncearenco et al., 2014), while still maintaining 
a critical role in the correct folding and functioning of these complexes (George and Heringa, 
2002; Jones and Thornton, 1995; Misra, 2017) 
1.1.1. Protein-protein interface interactions 
Protein-protein interfaces can occur between domains to form the tertiary structure and/or 
between subunits to form the quaternary structure (Han et al., 2007). Characterisation of both 
the intra-molecular interactions (which govern the manner in which the polypeptide chain 
associates with itself), and the inter-molecular interactions (which govern the manner in 
which the polypeptide chain associates with domains and subunits), is essential in 
understanding protein dimerisation (Nooren and Thornton, 2003). A high degree of 
specificity is required for the formation of the correct molecular associations, and for correct 
dimerisation (Brinda et al., 2002; Griffin and Gerrard, 2012; Janin et al., 1988). These 
interactions are crucial in the construction and folding of structural elements, and the 
formation of these interactions requires the interacting surfaces to have complementary shape 
and charge (Jaenicke, 1991; Jones and Thornton, 1996; Larsen et al., 1998).  
1.1.1.1. Geometric complementarity 
The geometric interlocking, charge reciprocation and amino acid side chain packing at the 
subunit-subunit interface is referred to as molecular complementarity (Jones and Thornton, 
1996). Protein subunits that exhibit complementary molecular surfaces reduce the  
solvent-exposed surface area between the subunits, allowing an increase in intramolecular 
hydrophobic effects. Intramolecular hydrophobic interactions are crucial in the correct 
orientation of individual subunits for the formation of complementary van der Waals 
interactions, hydrogen bonds and other electrostatic interactions during oligomerisation 
(Kuroda and Gray, 2016; Meyer et al., 1996; Novak, 2014).  
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Hydrogen bonds and salt bridges confer specificity to the association between subunits; 
however, geometric interface complementarity is required for complete specificity and 
association (Fersht et al., 1985; Larsen et al., 1998). The size of the buried surface area upon 
association, the packing density at the interface, the paucity of buried water molecules as well 
as the contour correlation between subunits are all defining features of geometric 
complementarity (Chothia and Janin, 1975; Janin et al., 1988; Kuroda and Gray, 2016).  
1.1.1.2. Physiochemical complementarity 
Hydrophilic interactions, hydrophobic interactions, amino acid composition and electrostatic 
interactions are the fundamental molecular interactions that govern the subunit interface 
(Bahadur et al., 2003; Janin et al., 1988; Tsai et al., 1997). Understanding their role in  
subunit-subunit association and dissociation is crucial, because these interactions are the 
determinants of proper folding, and hence the functioning, of proteins.  
The hydrophobic effect 
The hydrophobic effect is a result of the absence of hydrogen bonding between water and 
other non-polar groups dispersed amongst the hydrophobic patches of a protein (Dill, 1990). 
The contribution of the hydrophobic effect is more dominant in protein folding, but it is also 
essential in the stabilisation because the burial of non-polar amino acids via protein-protein 
associations is energetically-favourable (Balaji, 2015; Tsai et al., 1997) 
Protein interfaces may be composed of a central hydrophobic core surrounded by a 
hydrophilic charged region (Janin et al., 1988), or proteins may have numerous small 
hydrophobic patches with hydrogen bonds across the subunit interface (Larsen et al., 1998; 
Zhu and Karlin, 1996). The burial of non-polar amino acids is critical in oligomerisation, and 
the subunit-subunit interfaces of homodimers have been found to contain twice the buried 
surface area compared to other protein complexes (Bahadur et al., 2003).  
Amino acid composition 
The amino acid residues located along interacting surfaces within a protein are fundamental 
in determining the efficacy of the interactions occurring between two subunits (Cunningham 
et al., 1991; Fersht, 1984). Intersubunit interfaces are largely composed of charged residues, 
with 33% of the interface area consisting of the non-polar residues leucine, isoleucine, valine, 
cysteine, methionine and phenylalanine (Bahadur et al., 2003; Janin et al., 1988) whereas 
charged residues such as aspartic acid and glutamic acid contribute 14% to the interface area 
(Tsai et al., 1997). Despite the apolar nature of interfaces, arginine and leucine are the most 
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abundant interface-residues. Arginine is typically involved in numerous salt bridges across 
interfaces and also contributes the majority of hydrogen bonds across the subunit interface 
(Janin et al., 1988; Tsai et al., 1997). Amino acids can also confer stability because it has 
been shown that amino acid residues that protrude from one subunit into the surrounding area 
of an interacting subunit are implicated in securing the subunit-subunit association due to the 
electrostatic interactions occurring between these amino acids (Cunningham et al., 1991; 
Heringa and Argos, 1991).  
Electrostatic complementarity 
Electrostatic interactions such as salt bridges and hydrogen bonds are crucial in the formation 
of specific interactions (Fersht, 1984; Fersht et al., 1985). The relative positioning of charged 
side-chain residues at each interacting surface contributes towards complementarity (Jones 
and Thornton, 1996). Interactions between the N-terminal amide and C-terminal carboxyl 
group as well as interactions between charged chemical groups of ionisable residues such as 
arginine, histidine, lysine, aspartic acid and glutamic acid are responsible for the electrostatic 
interactions that take place at the subunit-subunit interface (Jones and Thornton, 1995; 
Wodak et al., 2015). 
Electrostatic interactions may be repulsive or attractive, and they may serve to either stabilise 
or destabilise protein-protein interactions (Fersht, 1984). Destabilising effects are a result of 
repulsion between groups with similar charges, whereas stabilising effects are as a result of 
the formation of salt bridges (ion pairs) between groups that are oppositely charged and 
within 4 Å of one another (Barlow and Thornton, 1983). Electrostatic interactions may also 
occur between residues that are further apart from one another on the polypeptide chain, and 
between residues of two different polypeptide chains via a charge cluster, as is the case with 
subunit-subunit electrostatic interactions (Barlow and Thornton, 1983; Brinda et al., 2002). 
1.1.2. Charge clusters  
A charge cluster describes the increased distribution of positively charged (lysine and 
arginine) or negatively charged (glutamic acid and aspartic acid) residues in a protein 
structure (Zhu and Karlin, 1996). Positive, negative and mixed charge clusters make more 
numerous contacts with residues within the cluster as opposed to residues in surrounding 




Charged clusters are often found at the surface of tertiary or quaternary structures, and 
function to stabilise the protein conformation (Kharrat et al., 2016; Kumar and Nussinov, 
2002). Mixed-charge clusters are involved in the formation of multidomain complexes and 
have been suggested as potential mediators of highly specific protein-protein interactions 
(Zhu and Karlin, 1996). Additionally, these clusters and have been shown to stabilise 
multidomain proteins through the formation of quaternary structure (Thompson et al., 2006). 
The residues that form charged clusters have been identified as key residues involved in 
dimerisation (Brinda et al., 2002) because they have been shown to force secondary structural 
elements of a protein to fold either by inward collapse, or through the development of a 
central interaction core (Heringa and Argos, 1991). Clusters responsible for dimerisation are 
scarce; however, charge clusters have been found near the centre of subunit-subunit 
interfaces, and the amino acid residues within these clusters are inaccessible to solvent (Zhu 
and Karlin, 1996).  
 Amino acid residues in charge clusters facilitate long-range interactions through side-chain 
clustering (Heringa and Argos, 1991). Clusters are more commonly composed of larger 
residues such as arginine, tyrosine, histidine, tryptophan, glutamic acid, phenylalanine and 
glutamine because a greater degree of contact is possible amongst these groups (Heringa and 
Argos, 1991). Polar residues are more commonly found in charge clusters than hydrophobic 
residues. Additionally, amino acids containing larger numbers of methyl groups are highly 
favoured to facilitate maximum surface contact for recognition and interaction (Heringa and 
Argos, 1991). 
1.1.3. Domain interface interactions   
Domains can be described as compact, local, semi-independent structural units within 
proteins (Richardson, 1981). Many proteins are composed of domains, and multidomain 
proteins often display domain repeats, particularly in eukaryotic proteomes (Bhaskara et al., 
2013; Schüler and Bornberg-Bauer, 2016; Vogel et al., 2004). It was previously thought that 
13 % of proteins contained domain-repeats (Marcotte et al., 1999), but more recently it has 
been shown that 25 % of proteins are repeat-containing (Pellegrini et al., 2012).  
The domain interface includes the buried surface area created during the association of 
domains and the interactions formed between domains (McCammon, 1998). The degree of 
interdomain interactions is dependent on the surface area of the domain interface (Jones et 
al., 2000). Understanding domain interface interactions is important because domains are 
highly conserved and they fold and associate to confer biological function (Bhaskara and 
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Srinivasan, 2011; Janin et al., 1988). The rearrangement and association of conserved 
domains assists the ordered assembly of numerous protein systems (Marsh et al., 2013). 
Hydrophobic cores within domains enable ordered assembly through the cooperative folding 
of numerous sites along the polypeptide chain, thereby enhancing the folding rate of a protein 
(Jaenicke, 1999; Marsh et al., 2013). Domains act as cooperative thermodynamic units during 
protein folding, and some domains even exhibit autonomous folding trajectories with distinct 
equilibrium unfolding transitions during equilibrium unfolding (Privalov, 1979; Rowe and 
Tanford, 1973). Cooperativity between domains is dependent on the structure, and the 
topology of a protein, and cooperative folding of multidomain proteins is reliant on dynamic 
coupling and communication between stabilising interactions (Itoh and Sasai, 2008; Malhotra 
and Udgaonkar, 2016a; Seelig, 2018). Non-cooperative domains show three to four states at 
equilibrium, whereas cooperative domains show only two states (Jaenicke, 1999), but 
cooperativity is not necessary for all proteins to fold correctly (Bhutani and Udgaonkar, 2003; 
Lakshmikanth et al., 2001; Malhotra and Udgaonkar, 2016b). It is possible for an overall 
reaction to show reduced cooperativity even though the events that constitute the reaction are 
fully cooperative as shown by the reduced cooperativity of multi-state transitions with 
discrete intermediates (Malhotra and Udgaonkar, 2016a). 
Determining the folding trajectory of a multidomain protein is complex because determining 
contact boundaries for individual domains remains challenging (Jaenicke, 1999). However, 
residues at the domain interface are conserved between protein families and these residues 
are responsible for the majority of domain interface interactions during protein folding 
(Valdar and Thornton, 2001). Studies conducted on numerous protein classes within a 
superfamily can, therefore, provide valuable information on the nature of both interdomain 
and intersubunit contacts, which will ultimately contribute to the knowledge base of how 






1.2. Protein folding 
The exact mechanisms behind protein folding are not fully understood; however, extensive 
research has elucidated the driving forces that are responsible for protein folding. A large 
entropic penalty is involved when disordered chains form the highly defined structure, and a 
large enthalpic penalty exists as a result of solvent interaction disruption (Anfinsen, 1973). 
Intramolecular contacts such as hydrogen bonding and electrostatic interactions stabilise 
protein structures, but hydrophobic interactions assist the folding process by counteracting 
the unfavourable entropic and enthalpic penalties (see section 1.1.3.1.).  
The amino acid sequence determines the driving hydrophobic force, as well as the stabilising 
electrostatic forces and hydrogen bonds within a protein. The importance of the primary 
structure has been thoroughly considered. Forty-five years ago, research conducted by 
Anfinsen proved that the information required for bovine pancreatic nuclease (RNase) to 
rearrange from a disordered state to a folded and fully functional state is contained within the 
primary amino acid sequence (Anfinsen, 1973). It was then concluded that the linear chains 
of amino acids found within all proteins assume a folded and functional three-dimensional 
structure through a process known as protein folding (Anfinsen, 1973). However, Levinthal 
postulated that it would take longer than the lifetime of the universe for a polypeptide chain 
to attain the native conformation (Levinthal, 1968) even though in vivo most proteins fold 
within a few seconds. The work conducted by these pioneers has resulted in one of the most 
intensely pursued research questions of our time: how do proteins fold? 
1.2.1. Folding models 
The two most generally accepted explanations for the principle of protein folding are the 
thermodynamic hypothesis proposed by Anfinsen (1973) and the kinetic hypothesis based on 
the calculations of Levinthal (1968). Several protein folding models have been proposed, but 
it is unlikely that a single mechanism describing protein folding exists. Therefore, protein 
folding models can only serve as an explanation of folding events occurring in a specified 
time frame.  
A visual representation of four models of protein folding is shown in figure 1A. The 
nucleation-condensation model proposes that native-like interactions are formed between 
several key residues to construct folding nuclei, which propagate the formation of secondary 
and then tertiary structures in a step-wise manner (Fersht, 1997). In contrast, the framework 
model (Figure 1A) proposes that hydrogen-bonded secondary structural elements are able to 















Figure 1: Visual representation of protein folding concepts 
(A) Visual representation of the diffusion-collision, hydrophobic collapse, nucleation-growth 
and nucleation-condensation models, respectively (Nickson and Clarke, 2010). (B) The 
classical specific pathway concept with distinct intermediates, as proposed by Levinthal. The 
presence of an error-dependent kinetic barrier (- - -) can affect certain populations, thereby 
mimicking multi-pathway folding (Englander and Mayne, 2014). (C) Schematic 
representation of the “new view” energy landscape. Entropy decreases as the protein 
approaches the native state. Folding may involve transient intermediates in local energy 




The diffusion-collision model (Figure 1A) expands upon the concept that secondary structure 
forms prior to tertiary structure because this model proposes that folding occurs by the 
diffusional collisions of structured microdomains (Karplus and Weaver, 1994). The 
successful collision of microdomains results in the cooperative folding of a protein to form a 
functional three-dimensional structure. The nucleation-growth model (Figure 1A) postulates 
that secondary structural elements are formed by numerous neighbouring residues, and that 
the structures formed act as propagation sites for step-wise folding (Wetlaufer, 1973). The 
hydrophobic collapse model (Figure 1A) proposes that folding is driven by the collapse of 
hydrophobic residues (Dill, 1985, 1990). Secondary structural elements, therefore, form as a 
result of restricted conformational space, with a bias towards the native structure (Dill, 1990). 
The unifying concept between the proposed models is that each model implies the existence 
of partially folded structures along the pathway. Additionally, researchers are certain that 
global folding occurs subsequent to all other folding events because correct folding of 
elementary processes and intermediate species must be complete in order for a protein to fold 
into a three-dimensional structure (Eaton et al., 2000).  
Numerous protein folding studies have been conducted resulting in the publication of several 
excellent review articles. However, protein folding researchers have not been able to reach a 
consensus for a unified mechanism for protein folding, and the protein folding problem has 
not yet been solved (Arai, 2018; Baldwin, 2017; Englander, 2000; Englander and Mayne, 
2014, 2017b; Finkelstein et al., 2017; Krishna and Englander, 2007). 
1.2.2. Levinthal, energy landscapes and foldons 
The classical specific pathway concept (Figure 1B) indicates that the folding process would 
take an enormously long time if a protein were to attain the correctly folded 
configuration by randomly sampling all the possible conformations (Levinthal, 1968). 
However, the short timescales of protein folding prove that proteins do not attain their native 
structure by a random process. Levinthal’s classical specific pathway concept was widely 
accepted for decades, until the “new view” of protein folding was proposed (Figure 1C) 
(Baldwin, 1994; Sali et al., 1994). The “new view” postulates that an ensemble of 
conformations follow parallel folding events to attain the native, folded state, forming the 
basis of the funnel-shaped energy landscape model (Baldwin, 1994; Chan and Dill, 1998; Dill 
and Chan, 1997).  
The energy landscape theory (ELT) proposes that folding is a conformational search on a 
conceptual folding funnel that is biased towards the native state (Baldwin, 1994; Plotkin and 
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Onuchic, 2002a). The top of the funnel is composed of random protein states that have high 
enthalpy and entropy compared with the states further along the funnel (Figure 1C). These 
random protein states move down the protein funnel so as to minimise enthalpic forces as the 
native state is attained (Dill and Chan, 1997; Dinner et al., 2000). Local minima in the funnel 
represent the presence of both stable intermediates and other proteins that exist along the 
folding pathway whereas a lack of intermediates is represented by a smooth funnel landscape 
(Figure 1C) (Baldwin, 1994; Chan and Dill, 1998; Plotkin and Onuchic, 2002b). 
The complex nature of protein folding, and the diversity of protein molecules, has resulted in 
an as yet unresolved difference in opinion regarding the folding mechanism employed by 
proteins. The modern many-pathway funnelled energy landscape model has been challenged, 
and a case for a defined folding pathway has been proposed  (Bai et al., 1995; Englander and 
Mayne, 2017b). Englander and Mayne argue that the ELT is too generalised and that the 
system can be applied to the folding of any protein, RNA or polymer. A detailed review of 
the studies that have elucidated and explored protein foldons (Gianni et al., 2003; Hu et al., 
2016, 2013; Xu et al., 1998) concludes that a foldon consists of approximately 25 residues 
that fold cooperatively, and that each foldon strip folds on a single pathway (Englander and 
Mayne, 2017b). The foldon-dependent protein folding theory has received support from a 
number of researchers (Baldwin, 2017; Bédard et al., 2008; Hu et al., 2016; Krishna and 
Englander, 2007), but it has also been contested that the claims made by Englander, Mayne 
and co-workers pertaining to the existence of foldons are false (De et al., 2017; Eaton and 
Wolynes, 2017; Yu et al., 2015). Eaton and Wolynes have argued that theory, experimental 
research and simulations provide an irrefutable case that proteins fold by multiple pathways 
and not by a single pathway (Eaton and Wolynes, 2017; Kim et al., 2014). Englander and 
Mayne conclude the argument stating that recent progress suggests that while the ELT has 
benefitted the field of protein folding greatly; it is “time to move on” towards a different 
vision (Englander and Mayne, 2017a). 
It is clear that the current conflict needs to be resolved before the nature of protein folding 
can be understood (Baldwin, 2017). Novel folding studies are conducted on a regular basis 
(Arai, 2018; Dautant et al., 2017; Finkelstein et al., 2017; Malhotra and Udgaonkar, 2016b; 
Moulick and Udgaonkar, 2017; Neupane et al., 2016; Puri and Chaudhuri, 2017) in an 
attempt to understand the various states that are available to a protein along the folding 
pathway. A deeper understanding of the various states in which a protein can exist will 
provide further evidence and will enable researchers to move towards a more unified 
understanding of the protein folding problem. 
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1.2.3. Protein folding pathway 
The folding pathway of a protein cannot be understood unless all of the states that are present 
along the pathway are characterised. Therefore, the folded, unfolded and stable intermediate 
states, as well as the transition states that link each stable state, need to be identified and 
characterised.    
1.2.3.1. The native state 
The native state determines the biological function of a protein and the contacts formed by 
the native state are pivotal. The three dimensional folded state of a protein is a highly ordered 
structure that is determined by the rotations occurring around single bonds in the backbone 
and sidechain atoms. The existence of the native state depends on the delicate equilibrium 
achieved between the destabilising loss of entropy (as a result of folding) and the stabilising 
hydrophobic interactions, hydrogen bonds and electrophilic and interactions. 
Hydrophobic interactions have been shown to be the dominant force driving protein folding 
(Dill, 1990; Heringa and Argos, 1991). Crystal structures of folded proteins have shown that 
the non-polar hydrophobic residues cluster together in the interior of the protein to form the 
stable core whereas polar and charged residues interact with solvent (Chothia and Janin, 
1975; Hubbard and Argos, 1994; Janin et al., 1988; Kauzmann, 1959). Water molecules 
surrounding the apolar amino acids assumes a conformation resulting in low entropy (to 
maximise positive hydrogen bonding between water molecules), whereas water molecules 
surrounding polar amino acids form a hydration shell that enables hydrogen bonding to the 
solution (Baldwin, 2014; Dill, 1990; Dill et al., 1995). Therefore, the stability of a protein is a 
balance between hydrophobic driving forces and entropic opposing forces (Dill, 1990; Pace, 
1990; Privalov, 1979).  
Long- and short-range contacts are important non-covalent interactions that assist in 
maintaining the stability of proteins. Electrostatic forces are long-range interactions that 
occur between the charged groups of ionisable sidechains. The stabilising effect of 
electrostatic interactions occurs when two oppositely charged groups are within 4 Å of one 
another (salt-bridge). However, a destabilising effect can also occur as a result of  
non-specific repulsive forces when identically charged groups are within 4 Å of one another 
(Barlow and Thornton, 1983; Neet and Timm, 1994; Pace, 1986). Hydrogen bonding is a 
weak short-range contact that occurs between an electronegative atom covalently bound to a 
hydrogen atom and another electronegative atom. Hydrogen bonding occurs between the 
carbonyl oxygen and the amide nitrogen of peptide bonds in protein structures, and these 
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bonds stabilise secondary structural elements such as helix-coil transitions (Dill, 1990; 
Grantcharova et al., 2001; Hubbard and Argos, 1994). Hydrogen bonding plays a role in the 
stabilisation of the folded, functional protein, but these interactions are not the dominant 
driving force in protein folding (Dill, 1990). Additionally, numerous interactions, such as 
disulfide bond formation, serve to stabilise the native protein. Disulfide bond formation is an 
important co- and post-translational modification that involves the formation of covalent 
interactions between intramolecular cysteines (Oka and Bulleid, 2013; Shimizu and 
Hendershot, 2009). Disulfide bond formation occurs in the endoplasmic reticulum, where 
electrons from reduced cysteines in the unfolded state are transferred to oxidoreductases of 
the protein disulfide isomerise family (Bader et al., 1999; Oka and Bulleid, 2013). The 
formation of disulfide bonds is an important step in the oxidative folding of numerous 
secretory proteins, because the correct formation of native disulfide bonds ensures the 
stabilisation and assembly of multidomain protein complexes (Shimizu and Hendershot, 
2009; Tu and Weissman, 2004). 
1.2.3.2. The intermediate state 
Folding has been shown to be a highly cooperative two-state process with no detectable 
intermediates for a number of smaller proteins (Jackson and Fersht, 1991; Kaplan et al., 
1997; Kiefhaber, 1995). However, examination of the folding mechanisms of larger 
multidomain proteins has elucidated the presence of intermediate and intermediate-like 
species as the protein moves from the denatured state towards a stable, native structure (and 
vice versa) (Baldwin, 1996; Creighton, 1990; Ptitsyn et al., 1990). Researchers have 
exploited numerous methodologies in an attempt to define and characterise intermediate 
forms (Fink et al., 1998). Stable thermodynamic intermediates are more easily examined, and 
detailed information regarding the structure of these intermediates can be obtained (Bhutani 
and Udgaonkar, 2003; Chamberlain et al., 1996; Englander, 2000; Fink et al., 1998). In 
contrast, kinetic folding intermediates have brief lifetimes. There are techniques that can be 
used to follow the folding process as it is occurring, these techniques provide good kinetic 
data, but limited structural information (Dasgupta and Udgaonkar, 2012; Kiefhaber, 1995; 
Krishna et al., 2004; Wallace et al., 1998a). 
Several types of intermediates have been observed in the equilibrium pathways of large 
multidomain proteins. Intermediates include dimeric, monomeric and molten globule states.  
The molten globule (MG) state has been identified as a productive intermediate between the 
native and denatured states for a number of globular proteins (Englander, 2000; Khan et al., 
2016b; Pande and Rokhsar, 1998). Two variations of the MG state have been characterised: 
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the ‘wet’ molten globule (WMG) and the dry molten globule (DMG). The WMG is a highly 
dynamic protein state that exhibits native-like secondary structure and a loosely- packed 
solvent exposed core (Fink et al., 1998; Ptitsyn et al., 1990). Conversely, the DMG is an 
expanded structure that lacks close-packing interactions, with a native-like structure that does 
not permit solvent penetration of the core (Shakhnovich, 1997; Shakhnovich and Finkelstein, 
1989). The role of molten globules in protein folding has been reviewed and discussed in 
great detail (Arai and Kuwajima, 2000; Baldwin et al., 2010; Baldwin and Rose, 2013; 
Englander and Mayne, 2014) and studies have shown that equilibrium molten globules may 
even represent kinetic intermediate analogs (Dabora et al., 1996; Jennings and Wright, 1993; 
Lim and Marqusee, 2017; Oliveberg, 1998; Raschke and Marqusee, 1997).  
Kinetics studies have detected transiently formed intermediates, even though these metastable 
states are only present in low stoichiometric amounts (Englander, 2000; Kiefhaber, 1995). 
Characterisation of intermediates detected in kinetic studies remains challenging, but 
advances in hydrogen exchange methods have made it possible to obtain informative 
structural information about transient intermediate states (Englander, 2000; Englander and 
Mayne, 2017b; Krishna et al., 2004). The presence of a kinetic intermediate indicates the 
occurrence of an event, such as cis-trans prolyl peptide bond isomerisation (Reimer et al., 
1998). The Xaa-proline peptide bond exists in either the cis or the trans conformation; with 
the trans conformation of non-proline peptide bonds displaying increased stability relative to 
the cis conformation. In native protein conformations,  one of the isomers will be favoured as 
a result of structural constraints of the native conformation (Kiefhaber et al., 1992; Reimer et 
al., 1998). In an unfolded protein, a specific Xaa-proline peptide bond will favour the trans 
conformation because of steric effects and as a result of n→π* interaction between the 
oxygen of the peptide bond and the consequent carbonyl carbon in the polypeptide 
(Hinderaker and Raines, 2003). Proteins that display the cis conformation in the native 
protein display isomerisation of 70-90% of the species during folding (Brandts et al., 1977) 
and identification of peptide bonds that undergo isomerisation during unfolding is key in 
determining the folding pathway of that protein (Eyles and Gierasch, 2000). Isomerisation 
does not necessarily result in the formation of rate-limiting intermediate species, but the rate-
limiting significance of cis-trans isomerisation during folding must be considered in the 
determination of the folding pathway of a protein (Cook et al., 1979; Kiefhaber et al., 1992; 




It has been suggested that intermediates direct the folding process (Kim and Baldwin, 1990; 
Walkenhorst et al., 1997); however, it has also been argued that intermediates could represent 
trapped species in the ELT, retarding the folding process (Jackson and Fersht, 1991; Silow 
and Oliveberg, 1997). The two differing viewpoints have resulted in a critical debate that 
discusses whether intermediate states are obligate on-pathway intermediates or whether they 
are trapped species that occur off the folding pathway (Baldwin, 1996; Jackson, 1998; 
Miranker et al., 1993). Despite much debate surrounding intermediates, identification and 
characterisation of both stable equilibrium intermediates and unstable transiently formed 
kinetic intermediates is critical. The characterisation of these states elucidates the (un)folding 
pathway of a protein and also provides useful insight into misfolding and aggregation. 
Misfolding and aggregation 
Protein folding most often results in a fully folded, functional, native structure in vivo. 
Consideration of the deep complexity of protein folding highlights that the process will not 
necessarily always occur without error. Regions that comprise the hydrophobic core of the 
folding structure are exposed to solvent when proteins are synthesised in the cell, resulting in 
unfavourable interactions with the other molecules (Ellis, 2001). Systems have evolved to 
prevent unfavourable interactions from resulting in misfolding, but particular conditions do 
result in failure of a protein to fold correctly or to remain correctly folded (Dobson, 2003; 
Englander et al., 2007; Moulick and Udgaonkar, 2017; Yu et al., 2015). Misfolded proteins 
are responsible for loss of function diseases such as cystic fibrosis as well as certain cancers 
(Dobson, 2003). Additionally, protein misfolding intermediates are also able to form 
precipitates known as protein aggregates (Dobson, 2003; Fink, 1998). Protein aggregates 
form insoluble fibrillar structures that accumulate in tissues like the brain and heart and result 
in diseases such as Alzheimer’s, Parkinson’s and diabetes (type II) (Chiti and Dobson, 2006; 
Dobson, 2003; Ross and Poirier, 2004).  
Characterisation of a misfolded intermediate from a small folding domain (Gianni et al., 
2010) indicates that it is possible to characterise not only stable and transient intermediates, 
but also misfolded intermediates. It is essential that we apply our knowledge of protein 
folding pathways to elucidate structural and mechanistic details of misfolded and 
aggregation-prone intermediates because these states are the potential drug targets of the 
future (Aguzzi and O’Connor, 2010; Borgia et al., 2013; de Oliveira and Silva, 2017; Khan et 
al., 2016a; Perchiacca et al., 2012; Woods et al., 2012). 
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1.2.3.3. The unfolded state 
The folded state is diverse between proteins, and this state has received much attention 
because of its biological relevance. Misfolding and aggregation have also been thoroughly 
pursued because these states are responsible for a wide variety of disease states. However, 
researchers have been less intrigued by the unfolded state of a protein because it was assumed 
that the unfolded state is a generic ensemble of highly disordered species that rearrange 
rapidly in the search for an energetically favourable configuration (Dill and Shortle, 1991; 
Griko, 1999). In tissues and cells, the unfolded state of a protein is in equilibrium with the 
native state of the protein and protein stability is defined as the difference in free energy 
between these two opposing states, indicating that the unfolded state is just as significant as 
the native state, when assessing the folding pathway (Dill and Shortle, 1991).  
The theoretical ideal of the unfolded state is a random coil, in which all conformations have 
comparable free energies, whereas the native state is well defined by a set of coordinates 
(Creighton, 1990). However, the unfolded state is less random than initially thought, as 
unfolded states show inter-residue interactions as well as varying degrees of residual structure 
(Dill and Shortle, 1991; Hammarström and Jonsson, 2005; Plaxco and Gross, 2001; Shortle, 
2001). Additionally, native-like topology has been shown to exist when proteins are unfolded 
under strongly denaturing conditions (Shortle, 2001). It is important to distinguish between a 
denatured and a fully unfolded protein state because the residual structure of a denatured state 
has significant implications in the refolding pathway and stability estimations of a protein 
(Myers et al., 1995; Soulages, 1998). 
The importance of the denatured state cannot be overlooked because these states are not 
random. The defined nature of the denatured state indicates that a pre-configuration of  
native-like bond angles may exist for a number of proteins, which would have significant 
implications for Levinthal’s paradox (Plaxco and Gross, 2001). Increasing the  
knowledge-base pertaining to both denatured states and unfolded ensembles is, therefore, an 





1.3. Protein unfolding 
In order to understand how a protein folds, it is also important to assess the unfolding 
mechanism of the protein. Elucidation of the unfolding mechanism of a protein can provide 
details about the stability, cooperativity, intermediate states, and the mechanism of action of 
the protein. Protein unfolding is an essential physiological process in vivo (see review 
Matouschek, 2003). Protein unfolding assists in protein degradation (Baumeister et al., 1998), 
membrane insertion (Gatzeva-Topalova et al., 2010; Stoychev et al., 2009), and even 
functionality (Dunker et al., 2001), but has also been implicated in a number of misfolding 
diseases (see section 1.1.3.2.).  
The unfolded state is neither generic, nor random, and as discussed above (section 1.1.3.3.), 
and not all proteins reach a fully unfolded, disordered conformation. Several proteins unfold 
via intermediates to a more defined denatured state, with a high degree of structural order 
(Hammarström and Jonsson, 2005; Plaxco and Gross, 2001). The unfolding of proteins, and 
how the denatured state is obtained, is of great importance because there are implications for 
the (re)folding pathway both in vivo and in vitro (Lapidus, 2017). 
1.3.1. The push-and-pull hypothesis  
Protein unfolding in vitro is a standard technique used to perturb the native state, and to 
promote the formation of intermediate states. Various methods are available to unfold 
proteins, but different methods produce unfolded and denatured states that are distinct from 
one another (Lapidus, 2017). Force (Ritchie and Woodside, 2015; Yu et al., 2015), 
temperature (Phillips et al., 1995; Privalov and Potekhin, 1986) and pH (Rami and 
Udgaonkar, 2001; Yeh et al., 2017) are all used as denaturing agents; however, the two most 
commonly used methods, which form the basis of the push-and-pull hypothesis, are  
high-pressure denaturation and chemical denaturation (de Oliveira and Silva, 2015). 
The molecular mechanism of pressure-induced denaturation is well-defined, and can be 
proven both experimentally and computationally (Lapidus, 2017).  High pressures (~2 kbar) 
initiate the hydration of hydrophobic amino acids located within the core of the protein (Font 
et al., 2006; Zhang and Smith, 1993). Hydration of the hydrophobic amino acids results in the 
formation of unstable cavities within the protein, which in turn causes the protein to unfold 




In contrast, the molecular mechanism of denaturation by chemical denaturants, such as urea 
and guanidine hydrochloride, is not yet fully understood. One possible mechanism is an 
indirect mechanism that involves the alteration of the structure of water to reduce the 
magnitude of the hydrophobic effect (Tanford, 1970). A second theory is a direct mechanism 
that suggests interactions between the chemical denaturant and the protein results in the 
disruption of native contacts (Khan et al., 2016b; Povarova et al., 2010; Privalov, 1979). 
Simulations using the same protein indicate that urea disrupts native conformation by 
forming hydrogen bonds with the peptide backbone (Baldwin, 2014; Kauzmann, 1959) 
whereas guanidine hydrochloride disrupts hydrophobic interactions between the side chains 
of amino acid residues (Bedouelle, 2016; de Oliveira and Silva, 2015). A recent study 
conducted by de Oliveira and Silva (2015) shows that the direct mechanism is the driving 
force of urea-induced unfolding, a conclusion supported by several computational studies 
(Khan et al., 2016b; Seelig, 2018).  
Pressure-induced unfolding differs from urea-induced unfolding in that cooperative units are 
often formed as a result of the non-homogenous nature of pressure-induced unfolding  
(de Oliveira and Silva, 2015). The compressibility effects of pressure on a protein causes 
hydrogen bond shortening within the cooperative units, favouring hydration to push water 
molecules against atoms within the protein (push effect) unfolding (de Oliveira and Silva, 
2015). Conversely, the direct preferential binding mechanism of urea results in the 
homogenous pulling of water molecules away from the protein structure (pull effect) to 
unfold the protein unfolding (de Oliveira and Silva, 2015). The dissimilar effects of urea and 
force on the unfolding of a protein are this explained by the push-and-pull hypothesis, which 
provides a molecular interpretation for the varying effects on unfolding (de Oliveira and 
Silva, 2015, 2017).  Additionally, the hypothesis provides possible explanations for the nature 
of cooperativity, which is critical in the evaluation of unfolding mechanisms observed via 
both equilibrium unfolding and kinetic unfolding studies. 
1.3.2. Equilibrium unfolding 
Equilibrium unfolding studies are useful in providing detailed information of the structure, 
stability, cooperativity and folding of the native, denatured and stable intermediate states 
(Neet and Timm, 1994). The conformational stability of a protein can be determined by 
disrupting the equilibrium that exists between the native and denatured state through the use 
of a denaturant (temperature, chemical, force, pressure, pH). A denaturant will shift the 
equilibrium towards the denatured state and re-establish equilibrium. The choice of 
denaturant is critical because, to obtain thermodynamic parameters, denaturation needs to be 
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reversible (Pace, 1986). Unfolding at varying urea concentrations is monitored by a number 
of spectroscopic probes (far-UV circular dichroism, intrinsic fluorescence, ligand binding, 
size exclusion high-performance liquid chromatography (see section 3.5), to produce an 
unfolding curve.  
Equilibrium unfolding curves are analysed by fitting the data to either a two-state model, or 
to a multistate model, to obtain the free energy change in the absence of denaturant 
(ΔG(H2O)) and the m-value (Myers et al., 1995; Pace, 1986). The two-state model suggests 
that only the native and denatured states exist along the unfolding pathway, and that these 
forms interconvert in a highly cooperative manner, whereas a multistate model suggests the 
presence of at least one stable intermediate along the unfolding pathway (Neet and Timm, 
1994; Pace, 1986; Soulages, 1998).  
The cooperative two-state model (N↔U) has been applied to many small monomeric proteins 
(Kim and Baldwin, 1990), and to several dimeric proteins (Gloss and Matthews, 1997; Main 
et al., 1999; Rumfeldt et al., 2008; Wallace et al., 1998a).  However, despite the numerous 
examples of two-state unfolding, the basis for cooperativity is not yet fully understood 
(Malhotra and Udgaonkar, 2016a). Cooperativity is determined by the stability of the native 
state, and the interactions that stabilise the native structure are cooperative because disruption 
of one or more of these interactions results in the destabilisation of other nearby interactions 
(Matouschek and Fersht, 1993; Privalov and Potekhin, 1986). Cooperativity in folding 
pathways is important because partially folded states show unfavourable interactions that are 
not present in the native or denatured states. Recently it has been concluded that stabilisation 
of the denatured state, induced by an increase in denaturant, can result in a two-state 
cooperative global unfolding transition over a large energy barrier (Malhotra and Udgaonkar, 
2015). Therefore, cooperativity might have evolved as a mechanism to decrease the 
propensity of a protein to aggregate (Malhotra and Udgaonkar, 2015, 2016a).  
If the unfolding data is not a simple two-state sigmoidal curve, or if the transition region 
obtained from multiple probes are not superimposable, the unfolding is multistate (Pace, 
1986). A general three-state model (N ↔ I ↔ U) would involve a native dimer, an unfolded 
monomeric intermediate and the unfolded/denatured state. A stable equilibrium intermediate 
can be detected because the species is significantly populated under equilibrium conditions, 
which enables the characterisation of the intermediate state. It is important to note that the 
deceptively simple two-state model does not necessarily exclude the possibility of high-
energy intermediates (Kim and Baldwin, 1990). High-energy intermediates can still populate 
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the unfolding pathway, without any observed effect on the thermodynamic unfolding curve, if 
the energy of the intermediate is sufficiently high (Englander, 2000; Zaidi et al., 1997). 
Therefore, to understand the complete unfolding pathway of a protein, the equilibrium and 
kinetic unfolding pathways must be assessed. 
1.3.3. Unfolding kinetics 
Equilibrium unfolding studies are fundamental in the design of kinetic experiments, and for 
the correct interpretation of the results (Matthews, 1987). Kinetic unfolding studies are useful 
in providing information about the transition states that populate the folding and unfolding 
mechanisms of proteins, and the mechanisms that govern transition state formation (Jaenicke 
and Rudolph, 1989). Kinetic unfolding studies are generally conducted by mixing protein 
with denaturant, and monitoring the progress of the unfolding reaction. Details on how the 
protein unfolds are obtained through the use of numerous probes, such as fluorescence, 
circular dichroism, ligand binding and mass spectrometry (Kiefhaber and Baldwin, 1995; 
Walters et al., 2009). 
Rapid mixing methods, such as stopped-flow studies, are commonly used to monitor the 
unfolding kinetics of proteins on a millisecond to microsecond timescale (Tonomura et al., 
1978). The unfolding reaction is initiated by rapidly mixing denaturants, such as urea, with 
native protein. The subsequent unfolding reaction can then be monitored using a suitable 
probe (Hoa, 1973; Roder et al., 2008). If only two species are present throughout the 
unfolding reaction and unfolding proceeds via a two-state mechanism, only one single kinetic 
phase will be detected (Kim and Baldwin, 1990; Utiyama and Baldwin, 1986). However, if 
the monophasic unfolding kinetic traces detected using multiple probes show variation, or if a 
burst phase is present, an intermediate species may be present (Zaidi et al., 1997). A burst 
phase indicates that unfolding events are occurring within the mixing time (dead-time) of the 
apparatus, and that there is a rapid accumulation of intermediate(s) in the early stages of 
protein unfolding (Lim and Marqusee, 2017; Roder et al., 2008). Protein unfolding 
intermediates may also be present if the unfolding traces are not monophasic. Multiphase 
kinetic unfolding traces can occur if multiple states of the native protein exist or if there is 
coupling between the unfolding reaction and peptide bond isomerisation (Kiefhaber et al., 
1995). Additionally, the formation of a structured transient intermediate will also result in 
multiphase kinetic traces (Galani et al., 2002; Shi et al., 2017; Walkenhorst et al., 1997; 
Žoldák et al., 2017).  
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The presence of kinetic unfolding intermediates indicates a complex unfolding pathway, 
which can be defined as either sequential or parallel. In a sequential unfolding pathway, 
kinetic events occur in a sequential manner, and intermediates may form either  
on- or off-pathway (Deng and Smith, 1999; Wallace and Matthews, 2002). Conversely, in a 
parallel unfolding pathway, events occur simultaneously (parallel) (Kiefhaber, 1995; Wallace 
and Matthews, 2002; Wright et al., 2004). It is also important to characterise whether an 
intermediate species is on-pathway or off-pathway. On-pathway unfolding intermediates are 
obligate intermediates that are required for the formation of the unfolded state, whereas  
off-pathway intermediates are non-productive and have been shown to slow down the 
unfolding process in a lag phase (for a detailed review see Baldwin, 1996).  
Complex unfolding reactions are difficult to interpret, and in order to determine whether a 
pathway is sequential or parallel a number of experimental tests should be employed (for a 
thorough and detailed review see Wallace and Matthews, 2002). However, the use of 
genetically modified proteins can also assist in the elucidation of complex unfolding (and 















1.4. Human glutathione transferase M1a-1a 
The canonical cytosolic glutathione transferases (GSTs) (EC 2.5.1.18) are a supergene family 
of multifunctional detoxification enzymes (Combes and Stakelum, 1961). Soluble 
mammalian GSTs are divided into eight classes: Alpha, Mu, Pi, Omega, Kappa, Sigma, Theta 
and Zeta (Board et al., 2000; Mannervik et al., 1992; Meyer et al., 1991; Pemble et al., 
1996). The Tau, Phi, Delta and Beta GST classes are found in plants, insects and bacteria, 
respectively (Hayes and McLellan, 1999). 
Evolution of the GST classes is thought to have proceeded via divergent evolution from the 
two electron transfer proteins glutaredoxin and thioredoxin (Ladner et al., 2004). The Kappa 
gene class encodes mitochondrial GST and has been proposed as the progenitor of the Theta 
gene class (Pemble et al., 1996). The cDNA sequence of the Alpha, Mu and Pi classes 
indicate that these classes have evolved from the Theta gene class, with evidence that class 
Mu diverged from the Theta precursor prior to class Alpha and Pi (Allocati et al., 2006; 
Ladner et al., 2004; Pemble et al., 1996; Sheehan et al., 2001). Evolutionary distinctions 
between the various gene classes are also indicated by the three-dimensional structures of the 
enzymes. Differences in the catalytic site residues provide evidence that the class Theta 
enzyme is an evolutionary precursor because an essential serine residue is present at the 
catalytic site of class Theta, whereas the other gene classes contain a highly conserved 
tyrosine residue (Armstrong, 1997). There is also evidence for class Theta as a precursor 
protein at the dimer interface because classes Alpha, Mu and Pi differ from older GSTs in 
that the dimer interface of these proteins is curved rather than flat and a hydrophobic lock-
and-key interaction exists between the subunits of these classes in place of hydrophilic 
contacts (Armstrong, 1997; Ladner et al., 2004; Piromjitpong et al., 2007). 
1.4.1. Structure  
Human glutathione transferase M1a-1a (hGST M1a-1a)
1
 is composed of two ~28 kDa 
subunits, each consisting of 217 amino acids. In accordance with other GST structures, each 
subunit of the homodimeric hGST M1a-1a is composed of two domains: the smaller 
thioredoxin-like N-terminal domain (domain 1) and the all α-helical C-terminal domain 
(domain 2). The domains are separated by a short six residue interdomain linker region 
(Figure 2) (Hayes and Pulford, 1995; Ji et al., 1992; Sheehan et al., 2001). 
 
1hGST M1a-1a refers to human GST from Mu class that is composed of two type 1a allelic subunits. The nomenclature used 



















Figure 2: Structural features of hGST M1a-1a 
(A) The cartoon representative of hGST M1a-1a shown down a two-fold axis shows the 
smaller N-terminal thioredoxin-like domain 1 (green) and the larger all α-helical C-terminal 
domain (cyan). The Mu loop (dark blue) is located near the active site. The F56 key residue 
(magenta) and the conserved R81 (red) stabilise the quaternary structure of the protein.  
(B) The mixed charge cluster at the subunit interface is composed of residues C77 (green), 
R81 (red), E90 (orange), D97 (yellow), E100 (dark blue) and F154 (cyan). R81 interacts with 
E90 and D97 from the opposing subunit whereas E100 interacts with F154 within the same 
subunit. C77 is unable to interact electrostatically. PDB file 1GTU was used to generate the 












































Domain 1 has been identified as the glutathione binding domain in thioredoxin (Kelley and 
Richards, 1987), glutathione peroxidase (Hayes and McLellan, 1999) and others (Martin, 
1995) and the highly conserved domain consists of four antiparallel β-sheets sandwiched 
between three α-helices (β1-α1-β2-α2-β3- β-α3). Domain 2 is the larger all α-helical  
C-terminal domain, composed of five amphipathic α-helices to create a hydrophobic protein 
core (Figure 2) (Hayes and Pulford, 1995; Ji et al., 1992; Sheehan et al., 2001).  
Each class displays unique structural features, such as the additional α-helix (α9) found in 
domain 2 of class Alpha GSTs (Sinning et al., 1993; Wilce and Parker, 1994). Class Mu 
contains the unique insertion of an extended, mobile Mu loop region connecting the sequence 
between β2 and α2 (residues 33-43) in domain 1 (Figure 2) (Ji et al., 1992). The Mu loop has 
been shown to contribute towards the substrate affinity of class Mu GSTs, but it is not 
essential for the maintenance of structure (Hearne and Colman, 2006). Despite the unique 
structural elements that are present in each class and the low sequence identity amongst 
classes, the quaternary structure and overall fold of GST enzymes is conserved. Dimerisation 
of the subunits is highly specific amongst GST gene classes and the interactions formed at the 
subunit interface govern the structure, stability and, therefore, the function of the enzyme. 
1.4.2. Function 
Homodimeric hGST M1a-1a shows a two-fold axis of symmetry, and each subunit contains a 
single active site at the subunit interface (Figure 2). The active site of each monomer is 
composed of a glutathione-binding site (G-site) and a hydrophobic binding site (H-site) for 
the binding of hydrophobic and electrophilic substrates (Figure 2) (Mannervik and Danielson, 
1988). The GSTs function in the intracellular detoxification of carcinogens, mutagens and 
other toxic compounds via catalysis of a reduced glutathione (GSH) nucleophilic attack on 
non-polar compounds (Mannervik and Danielson, 1988; Sheehan et al., 2001). The reaction 
serves to metabolise xenobiotic compounds that are then dispelled through the mercapturate 
pathway (Sheehan et al., 2001). The following scheme represents the general reaction 
between GSH and an electrophilic substrate (R) catalysed by GST (E) (Armstrong, 1997): 
 
The enzyme binds GSH at the G-site and removes the GSH sulfhydryl group proton to yield a 
glutathionate anion-enzyme complex (GS-E) (Armstrong, 1997). The proton is released and 
the electrophilic substrate binds to the H-site. The nucleophilic addition of a thiolate to the 
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electrophilic substrate is followed by the elimination of the leaving group (R) from the 
electrophilic substrate (Armstrong, 1997). The GSR conjugate is released with the free 
enzyme (E) in the final stage of the reaction (Armstrong, 1997). 
The role of GSTs in toxicology is diverse and immense because of the multifunctional nature 
of these enzymes in vivo (Hayes and Pulford, 1995; Hearne and Colman, 2006; Henderson et 
al., 1998; Hou et al., 2007; Kinsley et al., 2008; Pajaud et al., 2012; Strange et al., 2000). 
Recently, it was found that GSTs play a role in neurological disorder progression (Kumar et 
al., 2017) and an increase in the levels of GST Mu in the cerebral cortex of patients with 
Alzheimer’s disease has been reported (Sidell et al., 2003). The different class Mu subunits 
possess distinct catalytic properties because the M1 subunits catalyse the conjugation of GSH 
to p-nitrobenzyl chloride and to trans-4-phenyl-3-buten-2-one whereas the M2 subunits 
catalyse the conjugation of GSH to 1,2-dichloro-4-nitrobenzene (Hussey and Hayes, 1993). 
Additionally, class Mu GSTs are of particular interests because they exhibit polymorphic 
expression of isoenzyme forms with varying function (Chenevix-Trench et al., 1995; 
Mannervik et al., 1992).  
Polymorphisms in the GST M1-1 are thought to increase brain tumour susceptibility (Ezer et 
al., 2002) as a result of altered catalytic activity. Additionally, hepatic GST M1a-1a has 
shown high activity towards 4-hydroxyalkenals, indicating that the protein may be involved 
in cellular defence against peroxidative damage (Hussey and Hayes, 1993; Mannervik et al., 
1988). The null phenotype of GST Mu has been associated with an increased risk of cancers 
because the enzyme is inactive, which eliminates the ability of the GST to detoxify 
carcinogens (Strange et al., 2000). The role of GST M1 in anticancer drug resistance is 
amplified by its role in ASK1 regulation (McIlwain et al., 2006). GST M1 regulates  
stress-induced apoptosis by binding to and inhibiting the activity of the MAP kinase kinase 
kinase ASK1 (Cho et al., 2001; Ichijo et al., 1997). Oligomerisation of GST M1 has been 
shown to release ASK1 and induce apoptosis in conditions such as oxidative stress and heat 
shock (Dorion et al., 2002). These functions indicate that class Mu GST enzymes are vital for 
cell survival, making them important targets for studies that will improve our understanding 
of GST-related diseases. 
1.4.3. Intersubunit interactions 
Subunit-subunit interactions act not only as stabilising forces for the individual tertiary 
subunit structures, but also assist in the formation of quaternary structure (Alves et al., 2006; 
Hornby et al., 2002; Sayed et al., 2000). Dimerisation is class specific and absolutely 
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essential for the functioning of the catalytic site, with no catalytically active GST monomers 
being present in solution (Abdalla et al., 2002; Gildenhuys et al., 2010; Thompson et al., 
2006). Dimerisation of ancestral GSTs, such as class Sigma and Theta, results in less burial 
of solvent accessible surface area upon dimerisation than the 14 % that has been reported for 
class Alpha, Mu and Pi GSTs (Board et al., 2000; Dirr et al., 1994). The differences observed 
are because of the more open dimer interface configuration observed in the ancestral GSTs 
(Board et al., 2000), compared with the V-shaped cleft configuration formed by the hydrogen 
and ionic bond interactions that occur between α1 and α3 in domain 1 and between α4 and α6 
in domain 2 of class Alpha, Mu and Pi GSTs (Dirr et al., 1994; Wilce and Parker, 1994). The 
dimer interface of class Beta is very slightly packed, but lacks the V-shaped cleft formed in 
other classes, which opens the dimer interface to bulk solvent (Allocati et al., 2006).  
Crystal structure analyses of class Mu GST have identified two major interactions at the 
subunit-subunit interface. The first is the hydrophobic interactions of a lock-and-key 
mechanism and the second is a cluster of hydrogen and ionic bond interactions that occur 
between the two subunits as a result of a mixed charged cluster (Alves et al., 2006; Dirr et al., 
1994; Hegazy et al., 2004; Ji et al., 1992; Reinemer et al., 1992). 
The lock-and-key motif is conserved amongst class Alpha, Mu and Pi GSTs, and the motif is 
responsible for a major hydrophobic intersubunit interaction (Reinemer et al., 1992; Sinning 
et al., 1993). A phenylalanine (F56) located between α2 and β3 (F52, Alpha; Y50, Pi) in 
domain 1 of one subunit is fixed into the hydrophobic cavity constructed by α4 and α5 of 
domain 2 of the interacting subunit (Figure 2) (Alves et al., 2006; Hegazy et al., 2006, 2004; 
Sayed et al., 2000; Vargo et al., 2004). Ancestral classes lack this interaction and are thought 
to compensate with increased electrostatic interactions in their predominantly hydrophilic 
interfaces (Meyer et al., 1991; Rossjohn et al., 1998; Stevens et al., 1998). It has been shown 
that the lock-and-key motif plays a significant role in the stabilising the predominantly 
hydrophobic dimer interface of class Alpha, Mu and Pi GSTs, but that it is not solely 
responsible for dimerisation (Sayed et al., 2000; Vargo et al., 2004).  
Charge clusters are a common and well-studied group of protein-protein interactions (see 
section 1.3.1.1.). A mixed charge cluster exists at the subunit interface of class Mu GSTS, 
even though the dimer interface is predominantly hydrophobic (Zhu and Karlin, 1996). 
Analysis of individual subunits did not reveal the presence of any charge clusters, indicating 
that the interdomain salt bridges that exist between interacting residues at the subunit-subunit 
interface are critical in the formation of the mixed charge cluster and the dimerisation of the 
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enzyme (Zhu and Karlin, 1996). The mixed charge cluster of hGST M1a-1a is composed of 
residues C77, R81, E90, D97, E100 and F154 (Figure 2B). R81 is conserved in class Pi and 
class Sigma and the charged residue forms salt bridges with E90 and D97 of the opposing 
subunit (Huang et al., 2008; Zhu and Karlin, 1996). Additionally, hydrogen bonds connect 
F154 from chain A with E100 from chain A and F154 from chain B with E100 from chain B 
(Zhu and Karlin, 1996).  The hydrogen bonds and ionic interactions formed within the mixed 
charge cluster are involved in the stabilisation of the quaternary structure of the enzyme 
(Hornby et al., 2002; Thompson et al., 2006; Zhu and Karlin, 1996). 
A sequence alignment of closely related GST structural neighbours (class Alpha, Mu from 
both rat and human, Pi, Sigma and Theta) revealed interesting details about the subunit 
interface residues (Figure 3). The subunit interface of hGST M1a-1a has 13 charged residues 
whereas rGST M1-1 has 15. The two additional charged residues are R67 and R77 in rGST 
M1-1 whereas in hGST M1a-1a these residues are H67 and C77 (Figure 3). The difference 
between the mixed charge cluster residue at position 77 could result in differences in subunit 
stability between the two class Mu enzymes. These differences could be as a result of the 
formation of I interdomain salt bridges between R77 of domain 1 and D97 and E100 of 
domain 2, within each subunit (Ji et al., 1992). Furthermore, the symmetrically equivalent 
R77 in each rGST M1-1 subunit is structurally conserved (R70, Pi; R68, Sigma) and the two 
guanidino groups of R77 in opposing subunits stack together near the dimer two-fold axis (Ji 
et al., 1992). The hydrophobic C77 is unable to interact electrostatically, and the substitution 
of the residue in hGST M1a-1a could affect the properties of the subunit interface. Therefore, 
C77 in hGST M1a-1a may result in an altered dimerisation mechanism and conformational 
stability compared with rGST M1-1. 
1.4.4. Conformational stability and folding 
Dimer interface interactions affect the stability of proteins, and the obligate dimeric nature of 
GSTs suggests that subunit interactions are of great importance in the proper folding, and the 
maintenance of stability, of quaternary structure (Rumfeldt et al., 2008). Furthermore, these 
interactions ensure that heterodimers can only occur naturally between members of the same 
class (Pettigrew and Colman, 2001; Stenberg et al., 2000). The monomer-dimer transition of 
GSTs is relevant in the physiological functioning of these enzymes (Fabrini et al., 2009). 
Monomeric forms of GSTs have been reported inside cells using antibody reactions. For 
example, hGST P1-1 appears to be bound to JNK in a monomeric form (Adler et al., 1999; 





Figure 3: Structure-based sequence alignment of related GSTs 
The structure-based sequence alignment shows class Theta (1LJR), Alpha (1K3Y), Mu from 
human (1GTU), Mu from rat (2GST), Pi (1AQW) and Sigma (2GSQ). The key residues from 
the lock and key motif (magenta) as well as the mixed charge cluster residues C77 (green), 
R81 (red), E90 (orange), D97 (yellow), E100 (blue) and F155 (cyan) are highlighted in boxes 
to highlight the similarities and differences between the classes. The sequence alignment was 
performed using the Clustal Omega tool (Sievers et al., 2011). Clustal Omega is available for 














































The unfolding mechanisms of various GST classes are remarkably different, most likely 
because of the complex and varied dimer interface interactions that have been observed 
between the classes (Dirr, 2001). The GST isoenzymes from Schistosoma japonicum and the 
porcine class Pi enzyme (pGST P1-1) unfold via a highly cooperative two-state mechanism, 
with no intermediate species present in significant concentrations under equilibrium 
conditions (Dirr and Reinemer, 1991; Erhardt and Dirr, 1995). Human class Alpha GST 
(hGST A1-1) also unfolds via a two-state equilibrium unfolding mechanism; however, a 
native-like kinetic intermediate with partially dissociated domains also populates the 
unfolding pathway (Wallace et al., 1998b). 
The equilibrium unfolding model of hGST P1-1 is disputed amongst research groups: one 
research group supports the notion of structurally independent subunits and the presence of a 
stable monomeric intermediate (Aceto et al., 1992), whereas another group found no 
evidence of a stable monomeric intermediate (Gildenhuys et al., 2010). Aceto et al. (1992) 
show that hGST P1-1 denaturation follows a multistep process: the active dimeric structure 
dissociates into two structured, yet inactive monomers. Dissociation is thought to result in 
two inactive monomers via a bimolecular reaction rather than as a result of an unspecific 
effect caused by a chemical denaturant (Aceto et al., 1992). In contrast, the unfolding of 
hGST P1-1 examined through the use of both equilibrium and kinetic unfolding experiments 
by Gildenhuys et al. (2010) revealed that α2 unfolds to form a dimeric intermediate. The 
dimeric intermediate proceeds via a two-state cooperative unfolding mechanism and 
dissociation of the dimer is tightly coupled to the complete global unfolding of the enzyme 
(Gildenhuys et al., 2010). 
The ability of GST M2 and GST P1 monomers to dimerise indicates a high degree of 
similarity between the subunit interface of class Mu and class Pi GSTs (Pettigrew and 
Colman, 2001). However, class Mu and class Pi GSTs do not unfold via the same 
mechanism. The unfolding mechanism for rat class Mu isoenzymes (rGST M1-1 and  
tGST M2-2) has been elucidated (Hornby et al., 2000). The rat enzymes unfold in a three-
state mechanism via an inactive monomeric intermediate, even though the rGST M1-1 and 
M2-2 isoenzymes display differences in stability (Hornby et al., 2000; Luo et al., 2002). The 
Sigma class GSTs show an even more complex unfolding mechanism, which includes 




1.4.5. A modular approach to a complex investigation 
Elucidation of the mechanisms that govern protein (un)folding is difficult for complex  
homo- and heterodimeric proteins like GSTs. However, the deconvolution of complex 
systems can be achieved through the use of comparative studies using simplified models. 
Therefore, a simplified monomeric variant of hGST M1a-1a was created to study the 
unfolding mechanism of the homodimer.  
In order to create the monomeric mutant, the structural features of the subunit interface were 
considered (section 1.4.3.). Electrostatic interactions have been shown to govern 
dimerisation, and charged amino acids at the subunit interface of GSTs are responsible for 
these electrostatic interactions (Reinemer et al., 1992). A study on hGST P1-1 identified the 
charged amino acids Arg-70, Arg-74, Asp-90 and Asp-94 as residues that are sufficiently 
close to be able to participate in the intra- and intermolecular interactions governing 
monomer-dimer equilibrium, and mutation of these residues produced a monomeric variant 
of hGST P1-1 (Huang et al., 2008). Additionally, it has been shown that the simultaneous 
disruption of both the lock-and-key mechanism (F56S) and the mixed charge cluster (R81A) 
of rGST M1-1 results in the formation of a folded, monomeric variant protein.  
The tertiary structures of the WT dimer and mutant monomer needed to be conformationally 
comparative to use the mutant monomer in a modular approach because major differences 
between the subunits of the dimeric hGST M1a-1a (WT dimer) and the simplified monomeric 
variant (mutant monomer) would result in discrepancies between the unfolding pathways. 
The globular structure of the F56S/R81A monomer generated from rGST M1-1 was shown to 
be comparable to a single subunit within the dimer through the use of hydrogen-deuterium 
exchange mass spectrometry (HDX-MS) fluorescence and far-UV circular dichroism 
(Thompson et al., 2006). The differences in the subunit interfaces of hGST M1a-1a and  
rGST M1-1 (section 1.4.3.) do not affect residues F56 and R81, and the F56S/R81A 
monomeric variant is an ideal model to study the complex unfolding mechanism of dimeric 







1.5. Aim and objectives  
The numerous unfolding pathways utilised by various GST classes proves that determining 
the unfolding pathway of a multidomain oligomeric protein is highly complex. The use of 
different techniques and approaches may even elucidate different states that are populated 
throughout the unfolding mechanism. Differences between the primary structures within a 
class can result in the stabilisation of intermediates significantly enough that the unfolding 
mechanism is altered, as is the case for class Pi GST from pig (Erhardt and Dirr, 1995) and 
class Pi GST from the Bufo bufo embryo (Sacchetta et al., 1999). Comparative studies will 
develop our understanding of topology, amino acid sequence, the balance between entropy 
and enthalpy and propensity to form secondary structures (Nickson and Clarke, 2010). 
Therefore, an investigation into the unfolding pathways of each class of GST enzymes, from 
various organisms, will allow insight into fundamental questions about protein folding 
mechanisms. 
The main aim of this work is to propose an unfolding pathway for hGST M1a-1a. 
The specific objectives of this study were to: 
1. Perform site-directed mutagenesis to obtain a monomeric form hGST M1a-1a. 
2. Over-express and purify wild-type and mutant hGST M1a-1a. 
3. Assess the oligomeric status of wild-type and mutant hGST M1a-1a using size 
exclusion high-performance liquid chromatography. 
4. Determine the catalytic activity of wild-type and mutant hGST M1a-1a using the 
GSH-CDNB conjugation assay. 
5. Assess the secondary structure of wild-type and mutant hGST M1a-1a using far-UV 
circular dichroism. 
6. Assess the tertiary structure of wild-type and mutant hGST M1a-1a using intrinsic 
fluorescence and hydrogen-deuterium exchange mass spectrometry.  
7. Assess the stability of wild-type and monomeric mutant hGST M1a-1a using  
urea-induced equilibrium unfolding studies. 
8. Assess the structural features and (un)folding intermediates of wild-type and mutant 




Chapter 2: Experimental Procedures 
2.1. Materials 
The Escherichia coli T7 competent cells and the Quikchange
TM
 Site-Directed Mutagenesis 
kit were obtained from Stratagene (USA). E. Cloni EXPRESS competent cells were 
purchased from Promega (Madison, Wisconsin, USA). The GeneJET® Plasmid Miniprep 
Kit, dithiothreitol (DTT) and isopropyl-β-D-1-thiogalactopyranoside (IPTG) were obtained 
from Fermentas Life Sciences (St. Leon-Rot, Germany). Ampicillin was purchased from 
Roche Diagnostics (Mannheim, Germany). The compounds 1-chloro-2,4-dinitrobenzene 
(CDNB), 8-anilino-1-naphthalene sulfonate (ANS), reduced glutathione (GSH) and 
ethylenediaminetetraacetic acid (EDTA) were purchased from Sigma-Aldrich Co.  
(St. Louise, MO, USA). Ultrapure urea with a purity of 99.5% was purchased from Merck 
Chemicals (Darmstadt, Germany) and purification columns were purchased from GE 
Healthcare Life Sciences (Uppsala, Sweden). All other reagents used were of analytical 
grade.  
2.2. Plasmid preparation 
2.2.1. Wild-type   
Dr Ikechekwu Achilonu (University of the Witwatersrand, South Africa) designed the codon 
harmonised nucleic acid sequence encoding wild-type (WT) hGST M1a-1a with an  
N-terminal his6-tag and thrombin cleavage site. Additionally, a conservative and naturally 
occurring R205K mutation was incorporated to prevent thrombin cleavage occurring at this 
site within the protein sequence. The insert DNA sequence was synthesised and sub-cloned 
into the pET-11a plasmid (GenScript Corporation, USA). His6-hGST M1a-1a plasmid DNA 
was extracted and purified from an overnight culture using the GeneJET
TM
 Plasmid Miniprep 
Kit (Inqaba Biotech, Pretoria, South Africa). Plasmid DNA was sent to Inqaba Biotechnical 
Industries (Pty) Ltd (Pretoria, South Africa) for sequencing to verify the insert and to confirm 
the absence any other mutations. The his6-hGST M1a-1a plasmid DNA was transformed into 






2.2.2. F56S/R81A mutant  
His6-hGST M1a-1a dsDNA was used to design the oligonucleotide primers required to 
introduce the R81A mutation. His6-R81A mutant dsDNA was then used to design the 
oligonucleotide primers required to introduce the F56S mutation. Mutagenesis was therefore 
performed twice, with two separate sets of oligonucleotide primers in order to generate the 
his6-F56S/R81A double variant DNA sequence. Primers were synthesised by Inqaba 
Biotechnical Industries (Pty) Ltd (Pretoria, South Africa). 
R81A mutant: 
R81A forward: 5’atcttgtgctacattgccgccaagcacaacctgtgtggg3’ 
R81A reverse: 5’cccacacaggttgtgcttggcggcaatgtagcacaagat3’ 
The nucleotides in bold show the codon change from arginine (cgc) to alanine (gcc). 
F56S mutant: 
F56S forward: 5’ttcaagctgggcctggactctcccaatctgccctacttg3’ 
F56S reverse: 5’ caagtagggcagattgggagagtccaggcccagcttgaa3’ 
The nucleotides in bold show the codon change from phenylalanine (ttt) to serine (tct). 
The Quikchange
TM
 Site-Directed Mutagenesis kit (Stratagene, CA) was used to perform the 
site-directed mutagenesis according to the kit manual (Braman et al., 1996). The plasmid 
encoding F56S/R81A mutant hGST M1a-1a was used to transform XL10-Gold 
supercompetent E. coli cells. Plasmid DNA was obtained from cell culture grown using a colony 
selected from a plate treated with kanamycin and streaked with transformed cells. The 
GeneJET
TM
 Plasmid Miniprep Kit (Inqaba Biotechnical Industries (Pty) Ltd, Pretoria, South 
Africa) was used to extract plasmid DNA. Plasmid DNA was sent to Inqaba Biotechnical 
Industries (Pty) Ltd (Pretoria, South Africa) for nucleotide sequencing.  Nucleotide 
sequencing confirmed each mutation. The nucleotide sequences were aligned with the known 
mRNA sequence encoding WT hGST M1a-1a using BLASTN in the NCBI BLAST suite of 
(https://blast.ncbi.nlm.nih.gov/Blast.cgi) tools. The nucleotide sequence was translated using 
the translate tool on the ExPASy server (https://web.expasy.org/translate/) and the  
his6-F56S/R81A peptide sequence was aligned with the known WT hGST M1a-1a peptide 
sequence using the peptide alignment tool LALIGN on the ExPASy server. The his6-




2.3. Protein overexpression and purification 
The WT his6-hGST M1a-1a and the double mutant his6-F56S/R81A proteins were 
overexpressed in E. coli T7 cells grown in 2xYT media. The cells were initially incubated at 
37 °C until OD600nm reached 0.5 AU. Overexpression of the WT was induced using a final 
IPTG concentration of 1 mM, and cells were incubated at 37 °C overnight. The mutant 
overexpression was induced using an IPTG concentration of 0.2 mM, and cells were 
incubated at 20°C overnight. The cultured cells were harvested by centrifugation and 
resuspended in 50 mM Tris-HCl buffer at pH 8.0, containing 500 mM NaCl, 2 mM 
phenylmethylsulfonyl fluoride (PMSF) and 0.02% (w/v) NaN3 and stored at -20 °C. 
Before purification of the WT and mutant GST M1a, cells were thawed at 30 °C and 
sonicated on ice for eight rounds of 30 second pulses at medium intensity. The soluble 
fraction was obtained by centrifugation at 24000 x g for 30 minutes at 4 °C. The supernatant 
was applied to a 5ml Ni
2+
 column (GE Healthcare Bio-Sciences AB, Uppsala, Sweden), that 
was pre-equilibrated with 50 mM Tris-HCl buffer at pH 8.0, containing 500 mM NaCl,  
30 mM imidazole and 0.02% (w/v) NaN3. The column was first washed with equilibration 
buffer containing 30 mM imidazole to remove unbound protein. Subsequently, 4 ml fractions 
of the bound his6-hGST M1a-1a proteins were eluted with a 30-300 mM imidazole gradient 
in 50 mM Tris-HCl buffer at pH 8.0, containing 150 mM NaCl and 0.02% (w/v) NaN3. The 
absorbance at 280 nm was recorded and fractions were pooled. The pooled eluted protein was 
dialysed against 20 mM Tris-HCl buffer at pH 8.0, containing 200 mM NaCl, 5 mM CaCl 
and 0.02% (w/v) NaN3 overnight at 4 °C. Thrombin cleavage to remove the His-tag from the 
GST M1a proteins was performed using a 1 U/ml thrombin stock solution. One microlitre 
thrombin stock was used per millilitre of purified protein for 8 hours at 20 °C. Thrombin was 
removed using a 5 ml HiTrap Benzamidine FF (High Sub) column (GE Healthcare Bio-
Sciences AB, Uppsala, Sweden), which binds the thrombin (Guimarães and Bicca de 
Alencastro, 2002). The free his6-tag was removed from the solution of protein by binding it to 
a 5 ml Ni
2+
 column (GE Healthcare Bio-Sciences AB, Uppsala, Sweden) equilibrated with 50 
mM Tris-HCl buffer at pH 8.0, containing 500 mM NaCl, 30 mM imidazole and 0.02% (w/v) 
NaN3. The WT and mutant proteins were concentrated and dialysed into 20 mM sodium 
phosphate buffer at pH 7.45, containing 150 mM NaCl, 1 mM EDTA and 0.02% (w/v) NaN3 
for storage. The 20 mM sodium phosphate buffer at pH 7.45, containing 150 mM NaCl, 1 
mM EDTA and 0.02% (w/v) NaN3 buffer was optimised from the methods of Habig et al. 
(1974) to reduce protein aggregation by preventing metal-induced oxidation (Wingfield, 
1995). Samples were flash-frozen in 500 µL aliquots and stored at -80 °C. 
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2.3.1. Protein concentration determination 
The protein concentration of the WT and mutant were obtained using a dilution series. All 
protein concentrations of WT and mutant hGST M1a reported in this study refer to 
subunit/monomer concentrations, and were determined spectrophotometrically at 280 nm 
using the Beer Law  
A = ɛCl         (1) 
where A is the absorbance at 280 nm, ɛ is the molar extinction coefficient, C is the 
concentration and l is the path length (1 cm).  
The molar extinction coefficient was calculated according to Pace et al. (1995):  
ɛ = 5550ƩTrp + 1340ƩTyr + 150ƩCys              (2) 
where Trp, Tyr and Cys are the total number of Trp, Tyr and Cys in the 
subunit/monomer sequence of the proteins, respectively, and the numbers shown are their 





 was used for both the WT and mutant. 
2.3.2. SDS-PAGE 
The purity, homogeneity and molecular mass of the WT and the mutant were assessed using a 
4% stacking gel and 15% separating gel (Laemmli, 1970). Proteins were incubated with SDS-
PAGE sample buffer (0.125 M Tris-HCl, 4 % (w/v) SDS, 20% (v/v) glycerol, 5% (v/v) β-
mercaptoethanol and 0.02% (w/v) bromophenol blue, pH 6.8) for 5 minutes at 95 °C prior to 
loading. Samples were electrophoresed for 40 minutes at 180 V and gels were stained in 2% 
(w/v) Coomassie Blue R250 staining solution containing 13.5% (v/v) glacial acetic acid and 
18.75% (v/v) ethanol. The gels were destained with 40% (v/v) ethanol and 10% (v/v) glacial 
acetic acid until the background was clear. The distances migrated by individual proteins 
were compared to a set of known standards (molecular weight marker SM0431) 
2.4. Structural characterisation of the WT and F56S/R81A mutant  
2.4.1. Size exclusion high-performance liquid chromatography (SE-HPLC) 
The hydrodynamic volumes of the WT and mutant were characterised by high-performance 
liquid chromatography (SE-HPLC). A TSK Gel SuperSW2000 size-exclusion column with a 
resolution of 5–150 kDa (TOSOH Corporation, Tokyo, Japan) was used in conjunction with a 
TSK gel SWXL guard column (TOSOH Corporation, Tokyo, Japan). The column was 
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connected to a Shimadzu pump and equilibrated at 20 °C with 20 mM sodium phosphate 
buffer pH 7.0, containing 150 mM NaCl, 1 mM EDTA and 0.02% (w/v) NaN3. The pump 
maintained an isocratic pressure of approximately 900 psi at a constant flow rate of  
0.2 ml.min
-1
. Triplicate samples of 20 µM WT and 20 µM mutant were prepared and injected 
onto the column. A sample containing a mixture of 20 µM WT and 20 µM mutant was also 
run. The low molecular weight (LMW) gel filtration calibration kit (GE Healthcare  
Bio-Sciences AB, Uppsala, Sweden) was used to construct a standard curve. 
2.4.2. Far-UV circular dichroism 
Far-UV circular dichroism (CD) measurements were conducted with 1 µM and 10 µM of 
both WT and mutant proteins in 20 mM sodium phosphate buffer pH 7.45, containing 1 mM 
EDTA and 0.02% (w/v) NaN3. The Jasco model 810 CD spectropolarimeter was connected to 
a Peltier temperature controller. All experiments were conducted in a 2 mm cuvette at 20 °C. 
A data pitch of 0.2 nm, a bandwidth of 1 nm and a response of 0.5 s were used. Readings 
were taken at 222 nm over a 30 s time period with an average of five accumulations per 
sample at various urea concentrations. The continuous scanning mode was used for spectra 
recorded between 190 nm and 250 nm, and seven accumulations were collected per sample. 
CD spectra were recorded in triplicate in millidegree ellipticity, and buffer contributions were 
subtracted for all data collected. Triplicate readings were averaged and converted to mean 
residue ellipticity, [θ] (deg.cm2.dmol-1), using the following equation (Woody, 1995): 
 
[θ] = (100.θ )/ Cnl        (3)
   
where θ (mdeg) is the measured ellipticity signal at the respective wavelength, C is the 
protein concentration (mM), n is the total number of residues, and l is the path length (cm).  
2.4.3. Intrinsic fluorescence 
Fluorescence emission spectra were collected for 1 µM and 10 µM concentrations of both the 
WT and mutant proteins in 20 mM sodium phosphate buffer pH 7.45, containing 150 mM 
NaCl, 1 mM EDTA and 0.02% (w/v) NaN3. All spectra were collected on a Jasco FP-6300 
fluorescence spectrophotometer connected to a Peltier temperature controller set at 20 °C. A 
quartz cuvette with a 10 mm path length was used for all experiments. The excitation and 
emission bandwidths were set at 5 nm for 1 µM protein samples and at 2.5 nm for 10 µM 
protein samples, respectively. The emission spectra were collected using a scanning speed of 
200 nm/min. Intrinsic tryptophan fluorescence was monitored using an excitation wavelength 
of 280 nm and 295 nm. Emission was monitored between 290-500 nm. The spectra obtained 
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are an average of three accumulations per triplicate sample, and all spectra were corrected for 
buffer contributions. Denatured proteins were prepared in 20 mM sodium phosphate buffer 
pH 7.45, containing 150 mM NaCl, 1 mM EDTA and 0.02% (w/v) NaN3 with 8 M urea.  
A Bradford test was conducted to ensure that the same concentration of protein was present 
in all samples. Three-hundred microlitres of Bradford reagent was added to the protein 
samples in 20 mM sodium phosphate buffer pH 7.45, containing 150 mM NaCl, 1 mM 
EDTA and 0.02% (w/v) NaN3.The absorbance at 595 nm was measured in triplicate. 
2.5. Functional characterisation of the WT and F56S/R81A mutant  
2.5.1. Specific activity 
The enzyme-catalysed conjugation of CDNB to GSH at 20 °C was monitored 
spectroscopically by measuring the formation of 1-(S-glutathionyl)-2,4-dinitrobenzene at 340 
nm (Habig et al., 1974). The specific activity of the WT and mutant was assessed using the 
standard GSH-CDNB conjugation assay on a Jasco V-600 spectrometer. Samples of 1–10 nM 
protein were prepared in 100 mM sodium phosphate buffer at pH 6.5, containing 1 mM 
EDTA and 0.02% sodium azide in the presence of 1 mM GSH. The conjugation reaction was 
initiated by the addition of a 30 mM stock solution of CDNB solubilised in ethanol to create a 
final assay CDNB concentration of 1 mM and a final assay volume of 3 ml. The reaction was 
followed as linear progress curves by measuring the absorbance at 340 nm for 1 min at 20 °C. 
All reactions were corrected for the non-enzymatic controls. The specific activity of the 





) (Habig et al., 1974). The specific activity (μmol.min-1.mg-1) was 
determined by linear regression of a plot between the initial velocity of complex formation 
(μmol.min-1) versus protein amount (mg). All measurements were performed in triplicate and 
corrected for the non-enzymatic reaction rate. 
2.5.2. ANS binding 
A 20 mM ANS stock solution was prepared in 20 mM sodium phosphate buffer pH 7.45, 
containing 150 mM NaCl, 1 mM EDTA and 0.02% (w/v) NaN3. The concentration of the 




) (Weber and Young, 
1964). A concentration of 200 μM ANS was added to 1 μM of both the WT and mutant 
protein solutions prepared in 20 mM sodium phosphate buffer pH 7.45, containing 150 mM 
NaCl, 1 mM EDTA and 0.02% (w/v) NaN3.  The mixture was incubated at room temperature 
for 1 hour in the dark to promote the complete binding of ANS to the protein. The excitation 
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and emission bandwidths were set at 5 nm, and the emission spectra were collected using a 
scanning speed of 200 nm/min. Triplicate samples were excited at 390 nm, and emission 
spectra were recorded from 390-600 nm using a quartz cuvette with a 10 mm path length. 
The spectra obtained are an average of three accumulations per sample. All spectra were 
subsequently corrected for the fluorescence contribution from the unbound ANS. 
2.6. Urea-induced equilibrium unfolding 
Equilibrium unfolding studies were performed in the presence of urea so as to establish the 
degree of stability, (un)folding and cooperativity of the WT and mutant proteins. All 
unfolding experiments were performed at 20 °C in 20 mM sodium phosphate buffer pH 7.45, 
containing 150 mM NaCl, 1 mM EDTA and 0.02% (w/v) NaN3. Proteins were denatured in 
urea concentrations ranging from 0 M to 8.5 M. A 10 M urea stock, prepared as described 
previously (Pace, 1986), was used to prepare all urea samples The pH of the urea stock 
solution was adjusted to pH 7.45, the solution was filtered and the urea concentration was 
determined using a refractometer (Pace, 1986). All protein solutions were prepared in 
triplicate and allowed to equilibrate for 1 hour before the structure of the protein was probed 
using CD, intrinsic tryptophan fluorescence, ANS binding, SE-HPLC and dynamic light 
scattering (DLS). Aggregation throughout all equilibrium unfolding studies was monitored by 
Rayleigh scattering (Brahma et al., 2009). 
2.6.1. Reversibility of unfolding 
Triplicate samples of 1 µM WT and 1 µM mutant were incubated in 8.5 M urea for 1 hour at 
20 °C so as to denature the proteins. Refolding was induced by a six-fold dilution of the 
unfolded protein with 20 mM sodium phosphate buffer pH 7.45, containing 150 mM NaCl,  
1 mM EDTA and 0.02% (w/v) NaN3. The reaction was allowed to proceed for 1 hour at  
20 °C.  The recovery of the secondary and tertiary structure of both the WT and mutant was 
determined. Far-UV CD spectra (see section 2.4.3.) of the refolded proteins were recorded 
from 190-250 nm so as to determine the extent of recovery of the secondary structure of both 
the WT and mutant. These spectra were compared with spectra recorded for 1 µM native and 
1 µM denatured proteins to determine the percentage of secondary structure recovery. 
Similarly, fluorescence emission spectra recorded from 300-500 nm, using an excitation 
wavelength of 295 nm, were recorded for 1 µM refolded WT and 1 µM mutant proteins (see 
section 2.4.4.). These spectra were compared with native and denatured reference samples to 
calculate the percentage recovery of the tertiary structure.  
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In order to determine reversibility, triplicate samples of denatured WT and denatured mutant 
were diluted with 20 mM sodium phosphate buffer pH 7.45, containing 150 mM NaCl, 1 mM 
EDTA and 0.02% (w/v) NaN3 to final urea concentrations ranging between 0-8.5 M urea. 
Each reaction was left for 1 hour at 20 °C. Refolding was monitored by CD measurements 
obtained at 222 nm (see section 2.4.3.) and by tryptophan fluorescence emission (see section 
2.4.4.) at both 340 nm and 350 nm. 
2.6.2. Urea-induced equilibrium unfolding spectroscopic probes 
Secondary-structural changes were monitored by CD measurements obtained at 222 nm on a 
Jasco model 810 CD spectropolarimeter (see section 2.4.3.). Local changes in tertiary 
structure were monitored by tryptophan fluorescence on a Jasco FP-6300 fluorescence 
spectrophotometer as described (see section 2.4.4.). An excitation wavelength of 295 nm was 
used, and emission was monitored at 340 nm for folded protein and 350 nm for unfolded 
protein. CD measurements and intrinsic tryptophan measurements for unfolding experiments 
were carried out on both 1 μM and 10 μM protein samples.  
ANS binding to protein was measured using a final concentration of 200 μM ANS added to  
1 μM of WT and mutant and incubated at room temperature for 1 hour in the dark (see 
section 2.5.2). The concentration of the ANS stock solution was determined using the  




) (Weber and Young, 1964). ANS binding was 
monitored using an excitation wavelength of 390 nm, and emission was recorded from  
400-700 nm on a Jasco FP-6300 fluorescence spectrophotometer connected to a Peltier 
temperature controller set at 20 °C. The spectra obtained are an average of three 
accumulations per triplicate sample, and all spectra were corrected for unbound ANS in 
buffer. The relative ANS binding was calculated according to the methods of Chaudhuri et 
al., 1993.  
The hydrodynamic diameter of the various states of the WT and mutant in 20 mM sodium 
phosphate buffer pH 7.45, containing 150 mM NaCl, 1 mM EDTA and 0.02% (w/v) NaN3 
was probed using DLS. A Zetasizer Nano-S light scattering device (Malvern Instruments Ltd, 
UK) was used with the laser set at 523 nm. All solutions were filtered through a 0.1 µM filter 
to remove dust particles. Measurements are an average of five readings carried out on 5 μM 
protein. 
SE-HPLC was used to probe the oligomeric status and hydrodynamic volumes of the WT and 
mutant in 20 mM sodium phosphate buffer pH 7.0, containing 150 mM NaCl, 1 mM EDTA 
and 0.02% (w/v) NaN3 (see section 2.4.2.). The column was equilibrated with 20 mM sodium 
39 
 
phosphate buffer pH 7.0, containing 150 mM NaCl, 1 mM EDTA and 0.02% (w/v) NaN3 
containing the appropriate concentration of urea. The concentration of urea in the  
flow-through was determined using a refractometer to ensure that the column was 
equilibrated before applying the corresponding unfolded protein to ensure that no refolding 
could take place.  
2.6.3. Data fitting 
Savuka, a global analysis package developed by Professor Osman Bilsel, was used to fit the 
WT dimer and mutant monomer data obtained from the far-UV CD and intrinsic tryptophan 
fluorescence probes. The Savuka package is freely available online, with detailed download 
and installation instructions (http://www.osmanbilsel.net/software/savuka). 
The WT dimer data were fit using Savuka function 190, which is a custom model 
incorporated by Professor Bilsel to fit the data obtained in this study. Function 190 is a three-
state model that allows for a dimerisation (or dimer dissociation) event of both the native 
state and an intermediate state. The mutant monomer data were fit using Savuka function 
108, which was already available in Savuka. Function 108 is a three-state unfolding model 
that allows for the dimerisation of the intermediate only. The thermodynamic parameters 
ΔG(H2O) and m were obtained from the fits for both WT dimer and mutant monomer. 
2.7. Pulsed labelling hydrogen-deuterium exchange mass spectrometry 
(HDX-MS)  
The equilibrium unfolding of the WT and mutant was monitored by pulsed labelling HDX-
MS in an automated manner using the LEAP PAL HDX system (Leap Technologies, USA). 
The LC-MS/MS analysis was performed on an Agilent 1100 HPLC system coupled to an AB 
Sciex 6600 TripleTOF. Protein samples were diluted to yield a final concentration of 2 mg/ml 
protein. Protein was incubated in urea from 0 to 9 M in 20 mM sodium phosphate buffer pH 
7.45, containing 150 mM NaCl, 1 mM EDTA and 0.02% (w/v) NaN3. Protein samples were 
allowed to unfold for 1 hour to reach equilibrium. On-exchange reactions were initiated by 
transferring 4 µl of protein to a vial containing 16 µl D2O containing the same urea 
concentration as in the protein solution to ensure that refolding did not occur during labelling. 
Stock urea/D2O was prepared as previously described (Bai et al., 1993) and the urea 
concentration of each labelling solution was determined by refractometry. Following 
labelling, the solution was transferred to a vial containing 30 μL of 2 M guanidinium 
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hydrochloride, 100 mM TCEP at 0 °C to quench the labelling reaction and to minimise the 
back-exchange of incorporated deuterium. 
Quenched samples were injected onto a Poroszyme immobilised pepsin column 2.1 × 5 mm 
(Life Technologies) at a flow rate of 100 l/min using 0.1 % (v/v) formic acid to fragment 
the proteins. The resulting peptides were desalted on an Acclaim PepMap trap column  
(0.3 x 5 mm) for 2 min using 0.1 % (v/v) formic acid and separated at 200 l/min using a 
linear 10 min gradient of 10-40 % of 80 % acetonitrile/ 0.1% (v/v) formic acid on a Kinetex 
C18 column (2.1 x 5 mm). Proteolysis, desalting and peptide separation were all performed in 
a column incubated at 4 °C. The fully deuterated control was prepared by conducting 
deuteration overnight in a buffer supplemented with 0.02% (v/v) formic acid. The  
non-deuterated control was prepared using MilliQ water in place of D2O. The 6600 TipleTOF 
mass spectrometer was operated in Data Dependent Acquisition (DDA) mode for peptide 
identification, and a precursor scan was collected for deuterium labelling of each sample. In 
DDA mode, precursor scans were acquired from m/z 360-1500 using an accumulation time of 
250 ms followed by 30 product scans which were acquired from m/z 100-1800 at 100 ms 




 which fall in the 
mass range 360 -1500 m/z were automatically fragmented in Q2 collision cells using nitrogen 
as the collision gas. Collision energies were chosen automatically as a function of m/z and 
charge.  
2.7.1. Data analysis 
The peptide pool for both proteins was sequenced using PEAKS 6 (Bioinformatics Solutions 
Inc.). Deuterium exchange data for all peptides that are in common between the two proteins 
were processed using HD Examiner 1.3 (Sierra Analytics, LLC, Modesto,CA). Each peptide 
was manually filtered using the HD Examiner 1.3 interface, and 30 high-quality common 
peptides were selected. These 30 peptides covered 98.6 % of the sequence.  
The level of deuterium incorporated for each peptide at each unfolding condition was 
calculated as described previously (Zhang and Smith, 1993) through the use of HD Examiner 
1.3 software.  
The total number of amide peptide hydrogens in each peptide was calculated: 
N =  TN – 2 – TPro                  (4) 
where N is the total number of amide peptide hydrogens in the peptide, TN is the number of 
residues that can be deuterated within the peptide, and TPro is the number of proline residues 
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contained within the peptide. The value of 2 in the equation refers to the first two amino acid 
residues of a peptide, because they are unable to retain a deuterium at the peptide bond 
between them.  
Back-exchange of deuterium after labelling was corrected for by using the following formula 
(Zhang and Smith, 1993): 
DO  =    (m – m0%)    x N               (5) 
                     (m100% – m0%)  
     
where DO is the average number of deuterons per peptide, m is the average isotopic centroid 
of the partially deuterated peptide, m0% is the average isotopic centroid of the non-deuterated 
peptide, m100% is the average isotopic centroid of the fully-deuterated peptide and N is the 
total number of amide peptide hydrogens in the peptide. 
Peptide mass spectra that show both unimodal and bimodal distributions were analysed to 
identify the species present as the proteins unfold at urea concentrations ranging from 0-9 M. 
A number of isotope envelopes could not be clearly resolved, and the data was therefore not 
fitted to Gaussian areas in order to quantify the populations of the various states in each 
peptide. The population of folded and unfolded molecules was determined using the 
deuterium levels found in each peptide and comparing these levels to the deuterium levels 
found in the folded reference and in the denatured reference, respectively (Yang and Smith, 
1997).  
The percentage protection indicates what percentage of the population is folded in each 
peptide:  
 Percentage protection =              (%D – %Ddenatured reference)                                       (6) 
                                                       (%Dfolded reference – %Ddenatured reference) 
 
The percentage exposed indicates what percentage of the population is denatured:  
  
            Percentage exposed =                 (%D – %Dfolded reference)                                           (7) 
                                                    (%Ddenatured reference – %Dfolded reference) 
 
where % protection is the percentage of the population that is folded, % exposed is the 
percentage of the population that is denatured, %D is the percentage deuteration of the 
peptide in a particular concentration of urea, %Dfolded reference is the percentage deuteration in 
the folded reference of a particular peptide and %Ddenatured reference is the percentage deuteration 




Chapter 3: Results 
3.1. Plasmid sequence verification  
Sequencing of the plasmid DNA in the region coding for his6-hGST M1a-1a WT fusion 
protein indicated that the codon harmonised nucleic acid sequence encoding the WT protein, 
with an N-terminal his6-tag and thrombin cleavage site, contained the K205R mutation that 
was incorporated to prevent thrombin cleavage from occurring at this coding region (Figure 
4A). Sequencing results obtained for plasmid DNA purified from the plasmid encoding  
his6-F56S/R81A mutant hGST M1a confirmed that the desired double mutation had been 
incorporated, and that no additional mutations were incorporated during the thermal cycling 
reactions (Figure 4A and 4B). 
3.2. WT and F56S/R81A mutant protein purification 
The GST proteins were purified from the supernatants of sonicated E. coli cells, as described 
in section 2.3. The WT his6-hGST M1a-1a  was eluted from the Ni
2+
 affinity column using a 
0-100 % gradient of 30-300 mM imidazole, using 50 mM Tris-HCl buffer at pH 8.0, 
containing 150 mM NaCl, 300 mM imidazole and 0.02% (w/v) NaN3 (Figure 5A). The 
hexahistidine tag was then removed by thrombin cleavage to yield pure WT protein (Figure 
5B).  
His6-F56S/R81A mutant was also eluted using a 0-100 % gradient of 30-300 mM imidazole, 
using 50 mM Tris-HCl buffer at pH 8.0, containing 150 mM NaCl, 300 mM imidazole and 
0.02% (w/v) NaN3 (Figure 6A) and the hexahistidine tag was also removed to yield pure 
F56S/R81A mutant (Figure 6B). 
3.3. Structural characterisation of WT and F56S/R81A mutant  
The structural features of WT hGST M1a-1a and F56S/R81A mutant were assessed using 
SDS-PAGE, SE-HPLC, far-UV circular dichroism and intrinsic fluorescence.  
3.3.1. SDS-PAGE 
SDS-PAGE was used to determine the size and the purity of the WT and the F56S/R81A 
mutant. The size of each protein was determined by constructing a standard curve using a set 









Figure 4: Sequence identity of WT and F56S/R81A mutant 
(A) Sequence alignment showing F56S/R81A double mutation (orange box). The R205K 
mutation has also been incorporated to prevent cleavage by thrombin (blue box). WT and 
F56S/R81A mutant sequences were aligned using the Multiple Sequence Alignment Tool by 
CLUSTALW (http://www.genome.jp/tools-bin/clustalw). (B) Chromatogram showing 
truncated segment of F56S mutant sequence. The WT TTT codon for phenylalanine was 
replaced with the TCT codon for serine. (C) Chromatogram showing truncated segment of 
the R81A mutant sequence. The WT CGC codon for arginine was replaced with the GCC 
codon for alanine. The sequences were viewed using Chromas version 1.45 (32 bit) 
(http://www.technelysium.com.au/chromas.html; Technelysium Pty. Ltd., Helensvale, 
Australia).   
 
(A) 
Mutant codon for serine (F56S mutation) 
(B) 





Figure 5: Elution profiles of the WT protein 
(A) Elution profile of WT his6-hGST M1a-1a shows the absorbance at 280 nm of the effluent 
(blue) and the 30-300 mM imidazole gradient, using 50 mM Tris-HCl buffer at pH 8.0, 
containing 150 mM NaCl, 300 mM imidazole and 0.02% (w/v) NaN3 (green). Effluent was 
collected in 4 ml fractions. (B) Elution profile of WT protein cleaved overnight, and eluted 
by means of a Ni
2+
 affinity column coupled with a HiTrap Benzamidine FF (High Sub) 
column (GE Healthcare Bio-Sciences AB, Uppsala, Sweden), using 50 mM Tris-HCl buffer 






 Figure 6: Elution profiles of the F56S/R81A mutant protein 
(A) Elution of his6-F56S/R81A mutant shows the absorbance at 280 nm of the effluent 
(orange) and the 30-300 mM imidazole gradient using 50 mM Tris-HCl buffer at pH 8.0, 
containing 150 mM NaCl, 300 mM imidazole and 0.02% (w/v) NaN3 (green). Effluent was 
collected in 4 ml fractions. (B) Elution profile of F56S/R81A mutant cleaved overnight, and 
eluted by means of a Ni
2+
 affinity column coupled with a HiTrap Benzamidine FF (High Sub) 
column (GE Healthcare Bio-Sciences AB, Uppsala, Sweden), using 50 mM Tris-HCl buffer 




The proteins have approximately the same molecular mass under denaturing and reducing 
conditions (Figure 7). The size of the WT is ~29 kDa, which is consistent with results 
obtained for rGST M1a-1a (Hornby et al., 2000; Luo et al., 2002; Thompson et al., 2006). 
The size of the F56S/R81A mutant is ~28 kDa.  Both proteins are electrophoretically pure, as 
seen by the single bands (Figure 7 inset).  
3.3.2. SE-HPLC 
The hydrodynamic volume of a protein gives an indication of the oligomeric state of the 
protein. SE-HPLC was used to assess the hydrodynamic volumes, and therefore the 
oligomeric state, of the WT and F56S/R81A mutant.  
The single, symmetrical peaks in figure 8A indicate that WT (blue) and F56S/R81A mutant 
(orange) proteins are pure. WT elutes at 16.8 minutes and F56S/R81A mutant elutes at  
18.1 minutes, providing evidence that the F56S/R81A mutant has a lower molecular mass 
compared to the WT protein. A calibration curve was constructed and linear regression 
analysis was used to calculate the molecular masses of both proteins (Figure 8B). The mass 
of WT (measured using 20 µM protein) is 37 kDa and the mass of the F56S/R81A mutant 
(measured using 20 µM protein) is 25 kDa. The sample containing a mixture of  
20 µM WT and 20 µM F56S/R81A mutant shows that WT and F56S/R81A mutant elute 
separately (Figure 8C). The symmetrical peaks of the SE-HPLC elution profiles of mutant 
monomer spiked with WT dimer (Figure 8C) indicate that the mutant monomer is a stable, 
folded species that does not associate with itself or with the WT dimer subunit. This result 
proves that the hydrodynamic volume, and therefore the molecular mass of the WT are 
greater than that of the F56S/R81A mutant. The smaller than expected size of the WT dimer 
is because of the anomalous behaviour of globular GST proteins when they pass through  
size-exclusion columns (Alves et al., 2006; Chang et al., 1999; Hornby et al., 2000). SE-
HPLC data is not of a high enough resolution to determine the exact mass of proteins that are 
not globular, like GSTs. However, the data is of a high enough resolution to conclude that the 









Figure 7: SDS-PAGE analysis of WT and F56S/R81A mutant 
The calibration curve of known standards shows that WT (●) is ~29 kDa and F56S/R81A 
mutant (▲) is ~28 kDa. The standard curve was fitted to a straight line (R2 = 0.98). The 
equation of the fitted line is y = -0.015x + 2.2028. The SDS-PAGE gel (inset) that was used 





































Figure 8: SE-HPLC elution profiles of WT and F56S/R81A mutant 
(A) Elution profiles of WT (─) and F56S/R81A mutant (─) in contrast to the LMW gel 
filtration calibration kit standards (─). (B) Calibration curve of gel filtration kit standards 
fitted using linear regression. The equation of the straight line is y = -0.131x + 3.765 (R
2
 = 
0.99). WT (●) and F56S/R81A mutant (▲) are also indicated on the curve. (C) Elution profile 
of 20 µM WT spiked with 20 µM F56S/R81A mutant. 
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3.3.3. Far-UV circular dichroism 
The far-UV region ranges from 180-250 nm, which corresponds to the wavelength at which 
the amide bonds that link amino acids are able to absorb circularly polarised light (Woody, 
1995). The far-UV CD spectra of proteins exhibit characteristic features depending on the 
secondary structural elements of the polypeptide backbone of proteins (Woody, 1995).  
Far-UV CD is therefore an excellent probe to use when analysing the secondary structure of a 
protein.  
Far-UV CD spectra were obtained for WT dimer (1 µM monomer) and mutant monomer  
(1 µM) (Figure 9). The predominantly α-helical WT dimer and mutant monomer spectra both 
show a peak at 190 nm and minima at 208 nm and at 222 nm. These characteristics are in 
accordance with far-UV CD spectra for predominantly α-helical proteins (Woody, 1995). The 
native-like spectrum of the mutant monomer differs slightly from that of WT dimer because 
mutant monomer exhibits a reduced intensity at 190 nm and at 222 nm.  
3.3.4. Intrinsic fluorescence 
Protein molecules have three dominant fluorescent amino acids: phenylalanine, tyrosine and 
tryptophan. However, only tryptophan absorbs light maximally at wavelengths greater than 
295 nm, and can therefore be selectively excited (Lakowicz, 2006; Lakowicz and Masters, 
2008).  
The WT dimer and mutant monomer contain four tryptophan residues per subunit: W7, W45, 
W146 and W214 (Figure 2). Tyrosine and tryptophan were excited at 280 nm (Figure 10A), 
and tryptophan was selectively excited at 295 nm (Figure 10B). Fluorescence emission 
maxima values depend on the local environment of the tryptophan fluorophore. Figure 10 
shows that the emission maximum for both the WT dimer and mutant monomer is at 340 nm. 
However, the fluorescence emission intensity for the mutant monomer is reduced compared 
to that of WT dimer. The difference in intensity seen in figure 10 is not a result of different 
protein concentrations between the two samples, as they were confirmed to be the same (see 






Figure 9: Far-UV CD spectra for WT dimer and mutant monomer 
The resultant spectra for the WT dimer (1 µM monomer) (──) and mutant monomer (1 µM)  
(˗ ˗ ˗) in 20 mM sodium phosphate buffer pH 7.45, containing 1 mM EDTA and 0.02% (w/v) 
NaN3.are shown. Each spectrum represents the average obtained from three samples at 20 °C. 















Figure 10: Fluorescence emission spectra for WT dimer and mutant monomer 
(A) Tyrosine and tryptophan were excited at 280 nm. (B) Tryptophan was selectively excited 
at 295 nm. The emission spectra for WT dimer (1 µM monomer) (──) and mutant monomer 
(1 µM)  (˗ ˗ ˗)  indicate that both proteins emit maximally at 340 nm when excited at 280 nm 
and at 295 nm in 20 mM sodium phosphate buffer pH 7.45, containing 150 mM NaCl, 1 mM 
EDTA and 0.02% (w/v) NaN3. Each spectrum is the average of three separate protein 







3.4. Functional characterisation of WT dimer and mutant monomer 
The functional characteristics of mutant monomer were assessed in comparison with the 
functional characteristics of WT dimer. The standard GSH-CDNB conjugation assay was 
used to monitor specific activity, and ANS binding was used to monitor the non-substrate 
ligand binding properties of the protein. 
3.4.1. Specific activity 
The specific activity of both WT dimer and mutant monomer was determined using the 
standard GSH-CDNB conjugation assay (see section 2.5.1) (Habig et al., 1974). Linear 
regression analysis gives the slope of the linear progress curves, which corresponds to the 











A systematic error is observed in the plots in figure 11A because the plots do not intercept the 
origin at zero protein concentration. This is due to compensating for the non-enzymatic 
reaction. However, this does not impact the slopes (i.e., specific activity values) of the plots.  
3.4.2. ANS binding 
ANS has been shown to bind native GSTs, with little impact on the conformational stability 
and structure of the proteins (Erhardt and Dirr, 1995; Sluis-Cremer et al., 1996; Stevens et 
al., 1998). Free ANS in 20 mM sodium phosphate buffer pH 7.45, containing 150 mM NaCl, 
1 mM EDTA and 0.02% (w/v) NaN3 shows an emission maximum at 520 nm. ANS bound to 
WT dimer displays a spectral blue shift from 520 nm to 500 nm, and ANS bound to mutant 
monomer displays a shift from 520 nm to 490 nm (Figure 11B) because the mutant monomer 
ANS binding site is less polar than the WT dimer ANS binding site. These spectral blue shifts 
are in accordance with those reported in other studies performed on rGST M1a-1a (Hornby et 
al., 2000; Thompson et al., 2006). A 3-fold increase in fluorescence intensity is observed for 
ANS bound to mutant monomer, when compared with that for ANS bound to the WT dimer 








Figure 11: Functional characterisation of WT dimer and mutant monomer 
 (A) The specific activity for WT dimer (●) and mutant monomer (▲) was determined from 
the slope of the straight line fit. The experiment was performed in triplicate at 20 °C and the 
error bars show the standard deviation. (B) Fluorescence emission spectra of ANS bound to 
WT dimer (1 µM monomer) (──) and mutant monomer (1 µM) (˗ ˗ ˗). ANS was selectively 
excited at 390 nm and emission spectra were recorded from 400-700 nm. A free ANS control 
was used to correct each spectrum for free ANS in solution, and each spectrum is the average 
of three separate protein samples at 20 °C. 
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3.5. Urea-induced equilibrium unfolding 
A variety of spectroscopic probes can be used to monitor the unfolding and refolding 
transitions of proteins. Multiple probes should be used to gain an in-depth understanding of 
unfolding transitions under equilibrium conditions, because different probes report on 
changes that occur in different regions of the protein structure.   
The equilibrium unfolding transitions of GSTs have been studied using far-UV CD to 
monitor secondary structural changes, tryptophan fluorescence to monitor both global and 
local tertiary structural changes, and ANS binding to monitor the formation of hydrophobic 
patches and intermediates (Dirr and Reinemer, 1991; Erhardt and Dirr, 1995; Fabrini et al., 
2009; Gildenhuys et al., 2010, 2008; Hornby et al., 2000; Kaplan et al., 1997; Stevens et al., 
1998; Wallace et al., 1998b).  Furthermore, SE-HPLC can be used to determine the number 
and sizes of structural species present throughout the unfolding reaction, and DLS is useful in 
determining the hydrodynamic radius of various structural states as well as to ascertain 
whether aggregates have formed along the unfolding pathway. 
3.5.1. Recovery and reversibility of WT dimer and mutant monomer 
unfolding 
GST equilibrium unfolding studies show that GSTs unfold reversibly when using urea as a 
denaturant (Abdalla et al., 2002; Aceto et al., 1992; Gildenhuys et al., 2010, 2008; Hornby et 
al., 2000; Parbhoo et al., 2011; Stevens et al., 1998; Thompson et al., 2006; Wallace et al., 
1998b). The thermodynamic parameters of an unfolding transition can only be determined if 
the reversibility of the unfolding pathway is established (Pace, 1986, 1990). Therefore, one 
must prove that the native state of the protein can be recovered once the protein has been 
denatured in urea. WT dimer and mutant monomer denatured in 8.5 M urea were diluted with 
20 mM sodium phosphate buffer pH 7.45, containing 150 mM NaCl, 1 mM EDTA and 
0.02% (w/v) NaN3. The recovery of the native secondary structure and tertiary structure was 
assessed using far-UV CD (see section 3.3.3) and intrinsic tryptophan fluorescence  







Figures 12A and 12B show the spectroscopic data for refolded WT dimer and refolded 
mutant monomer in comparison with those for the native and denatured proteins. The spectra 
for both native and refolded WT dimer are similar and exhibit an emission maximum at 340 
nm when excited at 295 nm (Figure 12A). The percentage recovery of native signal 
calculated from these spectra is ~100 %. A similar recovery was also calculated from the  
far-UV CD spectra (Figure 12B). The recoveries of native signals calculated from the 
spectroscopic data for the mutant monomer were also ~100% (Figures 12C and 12D).  
Table A in the appendix shows the exact values used to calculate the percentage recoveries. 
The reversibility of the unfolding-refolding processes for both proteins, monitored by far-UV 
CD and fluorescence, is demonstrated by the overlapping unfolding and refolding curves 
shown in figure 13, with is no evidence of unfolding/refolding hysteresis. 
3.5.2. Unfolding monitored by tryptophan fluorescence and far-UV CD 
Intrinsic fluorescence and far-UV CD were used as probes to monitor the equilibrium 
unfolding of 1 µM WT dimer and 1 µM mutant monomer (see section 2.6.2). The proteins 
were unfolded in 0 - 8.5 M urea and allowed to reach equilibrium for 1 hour at 20 °C. 
Tertiary structural changes during unfolding were monitored using fluorescence emission 
intensity values at 340 nm and 350 nm when excited at 295 nm, and secondary structural 
changes during unfolding were monitored using ellipticity values at 222 nm (Figure 14). The 
data indicate that unfolding is multi-state for both the WT dimer and mutant monomer 
(Figure 14). There are two distinct transitions (unfolding events): the first unfolding event 
takes place between 0 M to 4.5 M urea and the second unfolding event begins at 
approximately 5 M urea and continues until the proteins are denatured. 
The change in the local environments of the four tryptophan residues (W7 and W45 are 
located in domain 1 and W146 and W214 are located in domain 2) is a good measure of the 
changes in the tertiary structure of the proteins as they unfold (Figure 14A and 14B). The WT 
dimer and mutant monomer unfolding curves in figure 14A are not superimposable during 
the first transition. However, the data do overlay during the second transition, indicating that 
the unfolding event(s) occurring during the second transition are equally cooperative and in 
all likelihood involve the same structural events. Figure 14B shows F350/F340 monitored by 
tryptophan fluorescence. At urea concentrations ranging between 2 M to 4.5 M the unfolding 





Figure 12: Recovery of the tertiary and secondary structure of WT dimer and mutant 
monomer 
(A) The fluorescence spectrum for native WT dimer (──) excited at 295 nm is almost 
identical to that of refolded WT dimer (˗ ˗ ˗). Both spectra show emission maxima at 340 nm, 
indicative of native protein because the emission maximum of denatured WT dimer (──) is 
350 nm. (B) The far-UV CD spectrum for both native WT dimer (──) and refolded WT 
dimer (˗ ˗ ˗) overlay fairly well. The two spectra are identical at 222 nm. (C) Fluorescence 
spectra for native mutant monomer (──) and refolded mutant monomer (˗ ˗ ˗) overlay and 
both exhibit an emission maximum at 340 nm when excited at 295 nm. (D) Native mutant 
monomer (──) and refolded mutant monomer (˗ ˗ ˗) far-UV CD spectra are almost identical. 
Both spectra exhibit identical troughs at 208 nm and at 222 nm. The final concentration for 
native, refolded and denatured protein was 1 µM (monomer) for WT dimer and mutant 
monomer. Each spectrum is the average of three samples at 20 °C. The percentage recovery 







Figure 13: Reversibility of WT dimer and mutant monomer unfolding 
The refolding curve of the WT dimer (1 µM monomer) (○) is super-imposable with the 
unfolding curve of the WT dimer (1 µM monomer) (●) when monitored using (A) intrinsic 
tryptophan fluorescence (F350/F340) and (B) far-UV CD ellipticity at 222 nm. The refolding 
curve of the mutant monomer (1 µM) (Δ) is super-imposable with the unfolding curve of the 
mutant monomer (1 µM) (▲) when monitored using (C) intrinsic tryptophan fluorescence 
(F350/F340) and (D) far-UV CD ellipticity at 222 nm. An excitation wavelength of 295 nm 
was used for fluorescence measurements. Refolding was allowed to proceed for 1 hour at 20 
°C. All experiments were performed in triplicate in 20 mM sodium phosphate buffer pH 7.45, 








Figure 14: Urea-induced equilibrium unfolding of WT dimer and mutant monomer 
monitored by intrinsic tryptophan fluorescence and ellipticity at 222 nm 
Unfolding transitions for the WT dimer (1 µM monomer) (●) and mutant monomer (1 µM ) 
(▲) protein were monitored by (A) fluorescence emission at 340 nm, (B) ratio of intrinsic 
fluorescence intensities at 350 nm and 340 nm and (C) far-UV CD ellipticity at 222 nm. All 
unfolding experiments were performed in triplicate at 20 °C in 20 mM sodium phosphate 




Unfolding monitored by ellipticity at 222 nm (E222 nm) is evidently multi-state for the WT 
dimer, but appears to be two-state for the mutant monomer (Figure 14B). However, the 
intrinsic fluorescence probe has shown that unfolding is not a simple two-state process for 
both WT dimer and mutant monomer (Figure 14 A and 14B). The unfolding curves are  
non-coincident from 4 M to 6 M urea, indicating that the secondary structural changes that 
occur during the unfolding of WT dimer and mutant monomer differ in both unfolding  
event 1 and unfolding event 2.  
The multi-state unfolding transitions indicates that stable intermediate state(s) are formed 
along the unfolding pathways of the WT dimer and mutant monomer, and before the data 
could be fitted to obtain thermodynamic parameters further investigation was required. 
3.5.3. Protein-concentration dependent unfolding  
A protein concentration-dependent unfolding study was conducted to understand at what urea 
concentration dimer dissociation occurs, and whether the intermediate(s) formed are 
monomeric or dimeric for both the WT dimer and mutant monomer. Urea-induced 
equilibrium unfolding transitions for the WT dimer and mutant monomer were monitored at 
 1 µM and at 10 µM protein concentrations. Intrinsic tryptophan fluorescence (F350/F340) 
and far-UV CD (ellipticity at 222 nm) were used as tertiary and secondary structural probes, 
respectively.  
The first event of WT dimer unfolding (0 M to 4.5 M urea) is dependent on protein 
concentration because the unfolding curves show a shift to a higher urea concentration when 
protein concentration is increased (Figure 15A and 15B). There is a clear shift to a higher 
urea concentration when the protein concentration is increased for WT dimer unfolding event 
2 when monitored using fluorescence (Figure 15A). However, the shift to a higher urea 
concentration is less evident when monitored by ellipticity at 222 nm (Figure 15B). Figure 
15C and 15D show that mutant monomer unfolding is protein concentration-dependent. 
Unfolding monitored using intrinsic tryptophan fluorescence shows a shift to a higher urea 
concentration for 10 µM protein compared with 1 µM protein at urea concentrations from  
3.5 M to 6.5 M (Figure 15C). Ellipticity at 222 nm was used to monitor changes in the 
secondary structure of mutant monomer and this probe elucidated a protein concentration-
dependent unfolding transition from 4.5 M to 6.5 M urea. The protein-concentration 
dependence of WT dimer unfolding is more apparent when monitored by intrinsic tryptophan 
fluorescence because the dataset is more populated than the dataset obtained using far-UV 




Figure 15: Protein concentration-dependence of WT dimer and mutant monomer 
unfolding 
WT dimer unfolding was probed by (A) intrinsic tryptophan fluorescence (F350/F340) and 
(B) far-UV CD ellipticity at 222 nm using 1 µM (monomeric concentration) (●) and at 10 
µM (monomeric concentration) (○). Mutant monomer unfolding was also probed by (C) 
intrinsic tryptophan fluorescence (F350/F340) and (D) far-UV CD ellipticity at 222 nm using 
1 µM (▲) and at 10 µM (Δ). An excitation wavelength of 295 nm was used for fluorescence 
measurements. All unfolding experiments were performed in triplicate at 20 °C in 20 mM 














3.5.4. Unfolding monitored by ANS binding  
ANS bound to native WT dimer displays a spectral blue shift from 520 nm to 500 nm and 
ANS bound to native mutant monomer shifts from 520 nm to 490 nm, indicating that the dye 
has bound the hydrophobic regions in both proteins (Figure 16A and 16B). Figure 16C shows 
that ANS binding steadily increases between 1 M and 4.5 M urea during WT dimer 
unfolding, whereas mutant monomer shows no increase in ANS binding with an increase in 
urea concentration in this range. The unfolding curves are coincident for both proteins 
between 5 M and 8 M urea and ANS binding decreases for both proteins until only the 
denatured protein species exists from 7 M to 8.5 M urea (Figure 16C). The Rayleigh scatter at 
390 nm shows no significant increase as the protein unfolds in various urea concentrations, 
indicating the absence of protein aggregation during unfolding (Figure 16D). 
3.5.5. Unfolding monitored by SE-HPLC  
Unfolding monitored by fluorescence emission when excited at 295 nm, ellipticity at 222 nm 
and ANS binding suggest that hGST M1a-1a unfolding might involve more than one 
intermediate. In order to identify all of the intermediates formed during unfolding, SE-HPLC 
was used to determine the hydrodynamic size of all protein species present at urea 
concentrations between 0 M and 8 M. 
Figure 17A-D shows that the native WT dimer (NWT) dissociates to form a monomeric 
intermediate (MWT) at 4.5 M urea (Figure 17E and 17F). An additional intermediate, which 
has a greater hydrodynamic volume than the native protein, is also formed at 4.5 M urea for 
WT dimer (Figure 17E and 17F). The large oligomeric intermediate (IWT) is only present 
when the monomeric intermediate (MWT) is present, suggesting that I forms as a result of the 
non-native association of M (Figure 17E and 17F). Figures 17J and 17K show that native 
mutant monomer (MMutant) becomes destabilised in 3 M urea (Figure 17L), resulting in the 
formation of the oligomeric intermediate (IMutant) (Figure 17 L-O). At 6 M urea oligomeric I 
is present for both WT dimer (Figure 17G) and mutant monomer (Figure 17P) unfolding, 
along with a fraction of denatured (D) protein. At urea concentrations above 7 M only 
denatured protein forms exist for the WT dimer (Figure 17H-I) and for mutant monomer 
(Figure 17Q-R). These data provide evidence that the oligomeric I is an additional 
intermediate present on the unfolding pathway of the WT dimer hGST M1a-1a and mutant 






Figure 16: Urea-induced equilibrium unfolding of WT dimer and mutant monomer 
monitored by ANS binding 
Fluorescence emission spectra of ANS bound to (A) WT dimer (1 µM monomer) and (B) 
mutant monomer (1 µM) in urea concentrations ranging from 0M to 8 M. ANS was 
selectively excited at 390 nm and emission spectra were recorded from 400-700 nm. The free 
ANS control (─) was used to correct each spectrum for free ANS in solution. Each spectrum 
is the average of three samples at 20 °C. (C) Unfolding transitions for 1 µM WT dimer (●) 
and 1 µM mutant monomer (▲) was monitored by ANS binding. All unfolding experiments 
were performed in triplicate at 20 °C in 20 mM sodium phosphate buffer pH 7.45, containing 
















Figure 17: SE-HPLC elution profiles of WT dimer and mutant monomer incubated in 
0 M to 8 M urea 
(A-I) WT unfolding (5 µM monomer) (─) and (J-R) mutant monomer unfolding (1 µM) (─) 
at 20 °C, in 20 mM sodium phosphate buffer pH 7, containing 150 mM NaCl, 1 mM EDTA 
and 0.02% (w/v) NaN3. The column was pre-equilibrated at the same urea concentration as 
the sample. Native proteins are labelled N, intermediate states are labelled I and denatured 




It is interesting to note that when the retention time of each peak was analysed, monomeric 
MWT at 5 M urea elutes at the same time as MMutant destabilised in 5 M urea (Figure 18). The 
oligomeric intermediates formed by both WT dimer (IWT) and mutant monomer (IMutant) are 
the same size in urea concentrations from 4.5 M to 6 M urea and the denatured states are also 
equal in size (Figure 18). IWT and IMutant will be referred to as I from this point forward.  The 
data in figure 17 are in accordance with unfolding curves for all probes being coincident 
throughout the second unfolding event. 
3.5.6. Unfolding monitored by DLS  
DLS was used to assess the hydrodynamic diameter of the predominant species at varying 
urea concentrations. Monodisperse samples of both WT dimer and mutant monomer indicate 
the WT dimer has a greater diameter than the mutant monomer. Native WT dimer has a 
diameter of 8.7 nm, in accordance with previously reported results (Lipin et al., 2008) (Figure 
19A). Native mutant monomer has a diameter of 5.6 nm (Figure 19B).  
The SE-HPLC data (see section 3.5.5) shows that at 3 M urea the native mutant monomer 
forms MMutant and IMutant (Figure 17L). The polydisperse sample at 3 M urea indicates that the 
mutant monomer has been denatured to such an extent that the hydrodynamic diameter of the 
protein is 8.7 nm (Figure 19B). Finally, from 5 M to 8 M urea the species present along the 
unfolding pathway are the same diameter for both WT dimer and mutant monomer (Figure 
19A and 19B), indicating that the same species are present in the polydisperse WT dimer and 
mutant monomer samples. . 
Absorbance spectra were recorded for each of the 5 µM protein samples that were used for 
the DLS measurements. The absorbance at 340 nm was recorded for each triplicate sample to 
confirm that the protein does not form insoluble aggregates during unfolding (Figure 19C). 
The absorbance at 340 nm remained low for each sample, indicating that no insoluble 







Figure 18: SE-HPLC retention time of each peak eluted for the WT dimer and mutant 
monomer when unfolded in 0 M - 8 M urea 
The various species present at different urea concentrations are shown for both WT dimer and 
mutant monomer. The native WT (NWT) elutes at a later time and therefore increases in size 
as the urea concentration is increased (●) until the dimer dissociates to form the monomeric 
intermediate MWT (○) and the oligomeric intermediate IWT (●). Denatured WT protein (DWT) 
is the least globular structure (●). The native mutant monomer (MMutant) elutes at the same 
time from 0 M to 3 M urea, indicating that no major structural changes have occurred (▲). 
MWT (○) and MMutant (▲) are the same size because they elute at the same retention time at  
5 M urea. MMutant (▲) becomes destabilised and associates to form IMuant (Δ). Oligomeric I 
formed by WT dimer (●) and mutant monomer (Δ) have similar retention times from 4.5 M 
to 6 M urea. Denatured mutant monomer (DMutant) forms at 6 M urea and is the only species 
present from 7 M to 8 M urea (Δ). DWT (●) and DMutant (Δ) elute at the same time, indicating 











Figure 19: Urea-induced equilibrium unfolding of WT dimer and mutant monomer 
monitored by DLS 
(A) DLS measurements showing the hydrodynamic diameter of (A) WT dimer (5 µM 
monomer) and (B) mutant monomer (5 µM) incubated in urea concentrations ranging from 0 
M to 8 M. (C) Absorbance values at 340 nm of WT dimer (5 µM monomer) and mutant 
monomer (5 µM) incubated in urea concentrations ranging from 0 M to 8 M. All readings 
were performed in triplicate and spectra are an average of the triplicate readings. All protein 
samples were incubated in urea for 1 hour at 20 °C in 20 mM sodium phosphate buffer  





3.5.7. Structure of the intermediates  
The secondary and tertiary structure of the WT dimer and mutant monomer was assessed at 
various urea concentrations in order to determine structural elements of each intermediate. 
However, this was challenging because a mixture of species exists at the various urea 
concentrations and it was not possible to isolate each of these species.  
Far-UV CD spectra of 1 µM WT dimer and 1 µM mutant monomer were compared under 
different urea conditions at 20 °C. The WT dimer maintains secondary structure in 0 M to 
 4 M urea (Figure 20A). At 4.5 M urea there is a loss in the secondary structure of the protein 
(Figure 20A). MWT and IWT are both present at 4.5 M urea and the spectrum at 4.5 M urea 
shows that both intermediates have a reduced secondary structure compared to that of the 
native WT. However, it is not possible to determine which intermediate contributes most to 
the signal. Secondary structure is gradually lost until the protein is denatured in 8 M urea. 
Mutant monomer shows a loss of secondary structure at 4 M urea (Figure 20B) even though 
all other unfolding data show that MMutant and IMutant are formed at 3 M urea. Again, this is 
because the far-UV CD spectra show an average of the signals from all species present. The 
mutant monomer shows a decrease in secondary structure until the protein is denatured in  
8 M urea. 
Intrinsic tryptophan fluorescence emission spectra of 1 µM WT dimer and 1 µM mutant 
monomer were compared under different urea conditions at 20 °C. The WT dimer shows no 
decrease in tertiary structure at 2 M urea (Figure 21A). However, at 3 M urea there is a loss 
in tertiary structure; this loss gradually increases until 5 M urea (Figure 21A). This differs 
from the far-UV CD data in that at 3 M urea the WT dimer still exhibits native-like secondary 
structure (Figure 21A). At 6 M urea the predominant species within the sample is denatured 
because the maximum emission shifts from 340 nm to 350 nm (Figure 21A) and at 8 M urea 
the protein is denatured. The mutant monomer shows a loss of tertiary structural contacts in  
2 M urea (Figure 21B). The tertiary structure of the species present at 4 M, 4.5 M and 5 M 
urea is the same because these spectra overlay very well (Figure 21B). Mutant monomer also 
shows that at 6 M the predominant species is denatured because the emission maximum shifts 








Figure 20: Secondary structure of WT dimer and mutant monomer incubated in 
various concentrations of urea 
Far-UV CD spectra for (A) WT dimer (1 µM monomer) and (B) mutant monomer (1 µM) 
incubated in 0 M to 8 M urea for 1 hour at 20 °C in 20 mM sodium phosphate buffer pH 7.45, 
containing 150 mM NaCl, 1 mM EDTA and 0.02% (w/v) NaN3. Each spectrum is the average 












Figure 21: Tertiary structure of WT dimer and mutant monomer incubated in various 
concentrations of urea 
Tryptophan emission fluorescence spectra of (A) WT dimer (1 µM monomer) and (B) mutant 
monomer (1 µM) incubated in 0 M to 8 M urea for 1 hour at 20 °C in 20 mM sodium 
phosphate buffer pH 7.45, containing 150 mM NaCl, 1 mM EDTA and 0.02% (w/v) NaN3. 
Each spectrum is the average of three samples and all spectra have been corrected for buffer 






3.5.8. Data fitting of urea-induced equilibrium unfolding 
Appropriate thermodynamic models could only be selected to fit the complex multi-state 
unfolding curves once the intermediate states had been detected using probes such as ANS 
binding (section 3.5.4),  SE-HPLC (section 3.5.5) and DLS (section 3.5.6). The WT dimer 
and mutant monomer unfolding data obtained from the intrinsic fluorescence and far-UV CD 
probes were globally fit using Savuka (see Section 2.6.3).  
The number of chains in the oligomeric intermediate (I), formed through the non-native 
association of the monomeric intermediate (M), is not well determined. However, it is 
possible that I is dimeric, with a loosely packed configuration (Figure 17). Therefore, the WT 
dimer and mutant monomer data were fit to functions that incorporate parameters for the 
dimerisation of M to form I. WT dimer unfolding data were fit using Savuka function 190, 
which is a three-state model in which both the native state (N) and the M state can associate 
to form dimers (Figure 22). Similarly, mutant monomer unfolding data were fit to Savuka 
function 108, which is a three-state unfolding model with only an intermediate (M) that 
dimerises (Figure 23). 
The thermodynamic parameters obtained from the fits are shown in Table 1. The parameters 
obtained from the fit were added to estimate the total ∆G(H2O)total and the total mtotal-value. 
The ∆G(H2O)total is 13.5±0.9 kcal.mol
-1









 for WT dimer 




 for mutant monomer unfolding. Additionally, the Cm1 
for WT dimer is 0.8 M urea greater than the Cm1 for the mutant monomer, whereas the Cm2 











Figure 22: Global fitting of the WT dimer unfolding events 
Solid lines (──) show the fit of WT dimer unfolding curves (●) monitored by (A) 
fluorescence using an excitation wavelength of 280 nm (B) tryptophan fluorescence 
(F350/F340) using an excitation wavelength of 295 nm and (C) far-UV CD  
(ellipticity at 222 nm). Global fitting was performed on Savuka v. 1 (developed by Professor 
Osman Bilsel http://www.osmanbilsel.net/software/savuka). The fits were obtained using 





Figure 23: Global fitting of the mutant monomer unfolding events 
Solid lines (──) show the fit of mutant monomer unfolding curves (▲) monitored by (A) 
fluorescence using an excitation wavelength of 280 nm (B) tryptophan fluorescence 
(F350/F340) using an excitation wavelength of 295 nm and (C) far-UV CD  
(ellipticity at 222 nm). Global fitting was performed on Savuka v. 1 (developed by Professor 
Osman Bilsel http://www.osmanbilsel.net/software/savuka). The fits were obtained using 
data obtained from the far-UV CD and intrinsic tryptophan fluorescence probes. 
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Table 1: Thermodynamic parameters obtained from urea-induced equilibrium 






















Cm1 (M) Cm2 (M) 
WT 
dimer 
5.4 ± 0.6   8.1 ± 0.3   1.2 ± 0.1   1.4 ± 0.1   3.8 6.0 
Mutant 
monomer 




























3.6. Pulsed-labelling HDX-MS 
Pulsed-labelling HDX-MS is a powerful technique used in determining the stability of 
various regions within a protein. The technique relies on the fact that the deuterium levels 
observed in each peptide show unfolding events that occur in the backbone of the intact 
protein. Specific structural events, such as intermediate formation, can be detected using this 
technique because unfolded regions are expected to be completely deuterated whereas folded 
regions will be undeuterated or minimally deuterated (Deng and Smith, 1998, 1999). Two 
stable intermediates were detected during equilibrium unfolding using numerous probes  
(see section 3.5). In order to identify the native folded regions from regions that are denatured 
and less structured, pulse-labelling HDX-MS was performed on WT dimer and mutant 
monomer under conditions that minimise the loss of deuterium (Deng et al., 1999; Krishna et 
al., 2004; Pan and Smith, 2004), as described in section 2.7. 
Labelled intact protein was digested with pepsin and over 200 unique peptides were 
identified for both the WT dimer and mutant monomer. The peptides were analysed and the 
mass spectra of 30 common peptides obtained for both proteins, were used for further 
analysis. The 30 common peptides cover 98.6 % of the sequence and were of good quality 
(Appendix Figure A and Figure B). Each peptide obtained after incubation in various 
concentrations of urea was compared with an undeuterated reference (UD), a deuterated 
native folded reference (0 M urea), an unfolded reference (8 M urea), and a fully deuterated 
reference (FD). Comparison of each peptide at each urea concentration with the reference 
samples, showed the extent of denaturation of each peptide at each condition. 
Mass spectra for each peptide at each condition were used to calculate the deuterium levels 
and to assess the intermolecular distributions of the various species present within each 
peptide throughout unfolding. Intermolecular distributions and deuterium levels were 
obtained using the mass spectra obtained for each WT dimer and mutant monomer peptide. If 
the rate of D2O exchange with the solvent is faster than the rate of refolding, the exchange 
occurs in the EX1 limit. Therefore, the addition of a denaturant such as urea will shift the 
reaction to the EX1 regime (Fang et al., 2011; Krishna et al., 2004; Liang et al., 2004; 
Miranker et al., 1996; Weis et al., 2006). Unimodal mass spectra could indicate regions that 
are fully folded or fully denatured depending on whether the isotope pattern is similar to that 
of the folded reference (0 M urea) or similar to that of the denatured reference (8 M urea). 
Unimodal and bimodal mass spectra were observed across the 30 common peptides obtained 
from WT dimer and mutant monomer denatured in various concentrations of urea.  
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The electrospray ionisation mass spectra of four representative peptides are shown to 
highlight differences in the modality of the mass spectra produced, when the WT dimer and 
the mutant monomer are exposed to various concentrations of urea. Peptide 10: 54-79 (Figure 
24A), peptide 14: 82-115 (Figure 52A) and peptide 18: 116-139 (Figure 26A) are all located 
at the domain interface and these three peptides all show broadly similar mass spectra 
envelopes signatures (Figure 24B-26B).  
Peptide 10: 54-79 (Figure 24) is located in domain 1, and this peptide contains the F56 
residue that was mutated to serine in the mutant monomer. The peptide forms β3 and β4 and 
part of α3 secondary structures (Figure 24A). Figure 24B shows the mass spectra of the WT 
dimer and mutant monomer at varying urea concentrations. The native (0 M) samples for 
both WT dimer and mutant monomer show an increased mass compared with the respective 
UD samples. At 4 M urea the WT dimer is still native, as shown by the unimodal peak 
corresponding to the native reference. At 4 M the mutant monomer shows a broadened 
unimodal peak. At 5 M and 6 M urea the mutant monomer shows a unimodal envelope that 
does not correspond with the 8 M denatured reference. The species that are shown in the 
monomeric unimodal mass spectra at 5 M and 6 M urea are more deuterated than the 8 M 
reference sample. The more complex WT dimer shows bimodal mass spectra at 5 M and 6 M 
urea. The peak intensity for the heavy envelope increases at higher urea concentrations, but 
does not correspond with the unimodal WT dimer peak at 8 M urea. The WT dimer and 
mutant monomer are not fully deuterated at 8 M because the peaks do not correspond with 
the FD reference peak.  
Peptide 14: 82-115 (Figure 25) is located at the dimer interface, and this peptide contains the 
R81 residue that was mutated to alanine in the mutant monomer. The peptide forms part of α3 
in domain 1 and the entirety of α4 in domain 2 (Figure 25A). The WT dimer and mutant 
monomer mass spectra of peptide 14 (Figure 25B) follow the same trend as the mass spectra 
of peptide 10 (Figure 24B). The WT dimer displays a unimodal peak at 0 M and 4 M, which 
correspond to the native protein envelope. At 5 M and 6 M urea the WT dimer displays 
bimodal isotope peaks with the lighter mass envelope corresponding to the native (0 M) 
reference and the heavy mass envelope representing an intermediate state (Figure 24B and 
25B). The mutant monomer displays unimodal isotope peaks from 4 M to 6 M urea. At 4 M 
urea the unimodal peak shows broadening towards the lighter mass range (Figure 24B and 
25B). The 5 M and 6 M urea peaks are more deuterated than the 8 M denatured reference 
peak (Figure 24B and 25 B).  
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Peptide 10: 54-79 z4 
                (A) 
 
                     
 
 












Figure 24: Structural location and mass spectra of peptic fragment number 10 (residues 
54-79) 
(A) Peptide 10:54-79 (green) is located in domain 1and contains the F56 residue (blue sticks). 
PDB: 1XW6 was used to generate the image using the PyMOL Molecular Graphics System, 
Version 2.0 Schrödinger, LLC. (B) Mass spectra of WT dimer (─) and mutant monomer (─) 
at various urea concentrations indicates the unfolding of the peptide in each protein. 
Undeuterated (UD) indicates native protein that was not exposed to deuterium and fully 
deuterated (FD) indicates the mass of a peptide that is cleaved from native protein that was 
exposed to deuterium for 18 hours. The m/z x-axis differs between the WT dimer and mutant 
monomer because the F56S mutation is present in this peptide.  
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Peptide 14: 82-115 z4 
















Figure 25: Structural location and mass spectra of peptic fragment number 14 (residues 
82-115) 
(A) Peptide 14:82-115 (red) contains the R81 residue (blue sticks). PDB: 1XW6 was used to 
generate the image using the PyMOL Molecular Graphics System, Version 2.0 Schrödinger, 
LLC. (B) Mass spectra of WT dimer (─) and mutant monomer (─) at various urea 
concentrations indicates the unfolding of the peptide in each protein. Undeuterated (UD) 
indicates native protein that was not exposed to deuterium and fully deuterated (FD) indicates 
the mass of a peptide that is cleaved from native protein that was exposed to deuterium for 18 
hours. The m/z x-axis differs between the WT dimer and mutant monomer because the R81A 




Peptide 18: 116-139 z4 
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Figure 26: Structural location and mass spectra of peptic fragment number 18 (residues 
116-139) 
Peptide 3:22-51 (blue) is located in domain 1. PDB: 1XW6 was used to generate the image 
using the PyMOL Molecular Graphics System, Version 2.0 Schrödinger, LLC. (B) Mass 
spectra of WT dimer (─) and mutant monomer (─) at various urea concentrations indicates 
the unfolding of the peptide in each protein. Undeuterated (UD) indicates native protein that 
was not exposed to deuterium and fully deuterated (FD) indicates the mass of a peptide that is 




Peptide 22: 167-185 z4 

















Figure 27: Structural location and mass spectra of peptic fragment number 22 (residues 
167-185) 
(A) Peptide 22:167-185 (magenta) is located in domain 2. PDB: 1XW6 was used to generate 
the image using the PyMOL Molecular Graphics System, Version 2.0 Schrödinger, LLC. (B) 
Mass spectra of WT dimer (─) and mutant monomer (─) at various urea concentrations 
indicates the unfolding of the peptide in each protein. Undeuterated (UD) indicates native 
protein that was not exposed to deuterium and fully deuterated (FD) indicates the mass of a 




Peptide 18: 116-139 (Figure 26) is located in domain 2, and forms part of α4 and the whole of 
α5 (Figure 26A). The WT dimer and mutant monomer amino acid composition are identical 
for this peptide. The 0 M native references for both WT dimer and mutant monomer have 
unimodal peaks (Figure 26B). At 4 M urea both WT dimer and mutant monomer have 
bimodal mass envelopes for peptide 18. However, the WT dimer shows a greater intensity at 
the lower mass envelope whereas the mutant monomer shows a greater intensity at the higher 
mass envelope. At 5 M urea the WT dimer and mutant monomer show an increase in the 
intensity of the heavy mass envelope, and the heavy mass envelope corresponds with the 
denatured 8 M reference sample (Figure 26B). At 6 M urea the WT dimer still shows a 
bimodal mass distribution but the mutant monomer only shows a unimodal mass spectrum 
that corresponds with the denatured 8 M sample.  
Peptide 22: 167-185 (Figure 27) is located in domain 2 of the protein, and forms part of both 
α6 and α7 (Figure 27A). The mass spectra of this peptide differs from the three 
aforementioned peptides in that this peptide displays only unimodal mass spectra that 
correspond with the native spectra for both WT dimer and mutant monomer up until 8 M urea 
(Figure 27B). At 8 M urea there is a shift to a heavier mass, indicating that peptide 22 
represents a highly, and equally, stable region in both proteins and proves that different 
regions within WT dimer and mutant monomer differ in stability. 
 The deuterium recovery for the 4 representative peptides was calculated by comparing the 
values of the denatured 8 M reference with the values of the deuterium levels obtained for the 
FD samples. The masses of WT dimer peptides 10, 14, 18 and 22 obtained from the 
denatured reference sample show that the peptides have an average of 6.3, 8.1, 6.6 and  
4.4 deuterons, respectively. Deuterium levels of the FD reference samples for peptide 10, 12, 
18 and 22 are 7.1, 9.4, 10.3 and 6.8. Therefore, the deuterium recoveries for the WT dimer 
peptic fragments were 89 %, 86 %, 64 % and 65 %, respectively. The denatured reference 
samples for mutant monomer showed an average of 7.8, 8.9, 6.7 and 4.8 deuterons for 
peptide 10, 14, 18 and 22. The FD reference samples for mutant monomer had an excess of 
11.4, 15.1, 10.7 and 7.2 for peptides 10, 14, 18 and 22. Therefore, the deuterium recoveries 
for peptide 10, 14, 18 and 22 obtained from mutant monomer were 68 %, 59 %, 63 % and 
67%, respectively. It has been reported that uncertainties between 10-500 ppm in mass 
measurements can be expected (Pan and Smith, 2004). The deuterium recovery results 
indicate that there is a greater percentage recovery for WT dimer than for mutant monomer, 
suggesting that the experiment is more reliable for WT dimer than for mutant monomer. 
Considering that the percentage recovery is calculated by comparing the values of the 
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denatured 8 M reference with the corresponding FD sample, it is more likely that the lower 
percentage recoveries indicate that the mutant monomer protein retains more structure in 8 M 
urea than the WT dimer protein, and not that the WT dimer data is more reliable. 
The average molecular mass of a peptide can be determined from the centroid values of all 
the isotope peaks and this gives the deuterium levels found in each fragment (Pan and Smith, 
2004; Yang and Smith, 1997). The deuterium levels found in each peptide were converted to 
the percentage deuteration. The percentage deuteration for each WT dimer and mutant 
monomer peptide were plotted for each urea condition (Figure 28). 
Peptides 3-10 differ in the percentage deuteration between the WT dimer and mutant 
monomer at 0 M (Figure 28A) and at 2 M urea (Figure 28B). The native mutant monomer is 
highly deuterated in this region whereas the native WT dimer is not. At 5 M urea (Figure 
28D) peptides 3-10 of the WT dimer become more deuterated and at 6 M (Figure 28E) and  
8 M urea (Figure 28F) the WT dimer and the mutant monomer are equally deuterated in this 
region. Peptides 11-19 contain the R81 residue, which is mutated to alanine in the mutant 
monomer. This region is equally deuterated at 0 M (Figure 28A) and at 2 M urea (Figure 
28B) for both proteins, indicating that both native proteins show no differences in structure in 
this region (amino acids 80-140). At 4 M urea the mutant monomer becomes more deuterated 
in this region, whereas the WT dimer remains minimally deuterated (Figure 28C). Only at  
5 M urea does the WT dimer become more deuterated in this region (Figure 28D). At 6 M 
(Figure 28E) and 8 M (Figure 28F) urea, the WT dimer and the mutant monomer are equally 
deuterated in this region. Peptides 20-26 are equally, and minimally, deuterated for the WT 
dimer and mutant monomer from 0 M to 6 M urea (Figure 28A, 28B, 28C, 28D and 28E). 
However, at 8 M urea there is an increase in the deuteration for both the WT dimer and 
mutant monomer (Figure 28E).  
The peptides were broadly grouped into three main groups based on the data in figure 28. The 
grouping was verified, and subsequently expanded, by determining the stability of each 
peptide within each group. The stability of each peptide was determined by an uptake plot for 
each corresponding WT dimer and mutant monomer peptide. An uptake plot is a graphical 
summary of the deuterium incorporation by each peptide during the unfolding of protein 
(Figure 29). The local unfolding midpoint (Cm), determined from the peptide uptake plot, is 
an indication of the stability of the protein region in which the peptide was originally located 







Figure 28: The percentage deuteration for each peptide at varying urea concentrations 
for WT dimer and mutant monomer 
WT dimer (●) and mutant monomer (▲) were exposed to (A) 0 M urea (B) 2 M urea (C) 4 M 
urea (D) 5 M urea (E) 6 M urea and (F) 8 M urea. Each peptide was cleaved from intact 
protein that had been allowed to unfold for 1 hour. The protein was then pulse-labelled with 










Figure 29: Deuterium incorporation for the 30 common peptides obtained under  
urea-induced equilibrium unfolding conditions 
The percentage deuterium uptake (% deuterated) when WT dimer (●) and mutant monomer 
(∆) are unfolded in 0 M to 8 M urea was calculated using the maximum exchangeable amide 
protons for each peptide. Each peptide was cleaved from intact protein that had been allowed 
to unfold for 1 hour. The protein was then pulse-labelled with urea/D2O for 10 seconds prior 
















Table 2: The Cm values for the 30 common peptides obtained for WT dimer and 
mutant monomer unfolding. Unfolded protein samples were pulse-labelled with urea/D2O 
for 10 seconds prior to acid quenching and pepsin digestion 
 
Least stable  Medium stable  Highly stable 
Key group
1
  Charged cluster  group
2
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4: 24-51 4.8 0 
 


























































































   
 
   
1
: The group is called the key group because it contains the F56 key residue in the WT dimer, 
which forms part of the conserved lock-and-key mechanism (see section 1.4). F56S/R81A is 
mutated to S56 in the mutant monomer to form the F56S mutation. 
2
: The group is called the charged cluster group because it contains the conserved R81 residue 
in the WT dimer, which forms part of the mixed charged cluster (see section 1.4). R81 is 
mutated to A81 in the mutant monomer to form the R81A mutation. 
3








The peptides representing the three unfolding groups are plotted onto the structure of hGST 
M1a-1a (PDB code 1XW6) (Figure 30A). The least stable key group (orange) contains 
peptides 3-10 and 27-30. This group contains the F56 key residue in the WT dimer and the 
S56 residue in the mutant monomer (F56S mutation). The Cm values for WT dimer range 
from 4.7 M to 5.1 M urea (Table 2). The mutant monomer Cm values could not be determined 
because these peptides were maximally deuterated throughout the experiment (Table 2). The 
medium stable charged cluster group is shown in blue on figure 30A. This group contains 
peptides 1, 2 and 11-19 (Table 2). The conserved R81 residue is located within the WT dimer 
peptides of this group (R81A in mutant monomer). The Cm values range from 5.5 M to 5.9 M 
urea for WT dimer and from 2.6 M to 5.0 M urea for the less stable mutant monomer (Table 
2). The highly stable core group consists of peptides 20-26 and is shown in green on figure 
30A. The Cm values of this group range from 7.1 M to 7.4 M for both the WT dimer and 
mutant monomer (Table 2).  
The population of denatured protein can be obtained if the bimodal peptides are compared 
with the low mass UD envelope and the high mass FD envelope. The envelopes were not 
always clearly resolved (monomer data at 4 M in Figure 26B), so all spectra could not be 
fitted to Gaussian distributions to obtain the areas under each envelope. Therefore, calculated 
deuterium levels were used to determine the populations of denatured molecules in each 
peptide at varying concentrations of urea, in accordance with literature (Pan et al., 2004; Pan 
and Smith, 2004; Rojsajjakul et al., 2004; Yang and Smith, 1997). The population of 
denatured protein in each unfolding stability group was calculated using equation 7 (section 
2.7.1) and plotted as a function of urea concentration (Figure 27B and 27C). The least stable 
key group (peptides 3-10 and 27-30) (Figure 30A) shows a transition midpoint at 
approximately 5 M urea for the WT dimer (Figure 30B), which is in accordance with the Cm 
values obtained for this group (Table 2). In contrast, the corresponding least stable key group 
transition from folded to unfolded mutant monomer is non-cooperative, and a transition 
midpoint cannot be determined (Figure 30C). The medium stable charged cluster group 
(peptides 1,2 and 11-19) show a transition midpoint of 5.5 M urea for the WT dimer and  
3.5 M for the mutant monomer (Figure 30), in accordance with the Cm values for this group 
(Table 2). The most stable core group (peptides 20-26) unfolds in the same manner for both 
WT dimer (Figure 30B) and mutant monomer (Figure 30C) and both proteins have unfolding 



















Figure 30: Population of unfolded WT dimer and mutant monomer in the three 
unfolding groups 
(A) Unfolding groups are highlighted on the WT dimer structure. The least stable key group 
(peptides 3-10 and 27-30) is shown in orange, the medium stable charged cluster group 
(peptides 1,2 and 11-19) is shown in blue and the most stable core group (peptides 20-26) is 
shown in green. F56 is shown in black and R81 is shown in red. PDB: 1XW6 was used to 
generate the image using the PyMOL Molecular Graphics System, Version 2.0 Schrödinger, 
LLC. (B) The fraction unfolded for WT dimer showing the least stable key group  
(peptides 3-10 and 27-30) (--●--), the medium stable charged cluster group (peptides 1,2 and 
11-19) (--●--) and the most stable core group (peptides 20-26) (--●--) (C) The fraction 
unfolded for mutant monomer showing the least stable key group (peptides 3-10 and 27-30) 
(--Δ--), the medium stable charged cluster group (peptides 1,2 and 11-19) (--Δ--) and the 
most stable core group (peptides 20-26) (--Δ--). Data points are the average of all the peptides 







Chapter 4: Discussion 
In-depth analyses have been conducted on the (un)folding pathways of numerous monomeric 
proteins, due to their relative structural simplicity. The fundamental principles learnt from 
this research can now be extended to larger and more complex multi-domain and oligomeric 
proteins. However, obtaining the (un)folding pathway for a multi-domain protein is 
challenging because of the numerous domain- and subunit-interface interactions, and the 
autonomous folding of individual domains.   
The dimeric structure of GST proteins is stabilised by multiple intersubunit interactions. The 
most prominent of these interactions are the conserved lock-and-key motif and the mixed 
charge cluster at the dimer interface (see section 1.4.3). The bulky F56 residue acts as the 
stabilising key residue in class Mu GSTs (Figure 2), but substitution of this residue alone is 
not sufficient to disrupt the dimeric structure (Hegazy et al., 2006; Hornby et al., 2002; Sayed 
et al., 2000). The simultaneous disruption of both the F56 key residue and the R81 residue in 
the mixed charge cluster is required for the formation of a monomeric GST, as shown in this 
study (Figure 8), and in a study conducted on rGST M1-1 (Thompson et al., 2006).  
The F56S/R81A monomeric variant of hGST M1a-1a was produced so that the complete 
unfolding pathway of hGST M1a-1a could be assessed at the subunit level, in the absence of 
the processes involved in dimer dissociation. The comparative study of the complex  
WT dimer and the less complex mutant monomer allowed for a more in-depth understanding 
of the unfolding pathway of hGST M1a-1a.  
 
4.1. The mutant monomer is a suitable model of the WT dimer subunit 
The success of this study relied on the fact that the mutant monomer is structurally 
comparable to the subunit in the WT dimer, and that the mutations have not resulted in any 
major tertiary structural alterations (see section 1.4.5). The 25 kDa mass obtained for the 
native mutant monomer using SE-HPLC (Figure 8B) corresponds with the 26 kDa molecular 
mass reported for the folded GST class Mu subunit (Armstrong, 1997). Additionally, the 
mass of the mutant monomer is similar to the masses obtained for the F56S/R81A monomeric 
mutant of rGST M1-1 (26 kDa) (Thompson et al., 2006), and other monomeric variants of 





The insertion of the F56 functional group into the hydrophobic cavity constructed by α4 and 
α5 on the opposing subunit anchors the region surrounding the mu loop in domain 1  
(Figure 2), thereby stabilising the active site of hGST M1a-1a (Alves et al., 2006; Sayed et 
al., 2000). The F56S mutation increases the dynamics of the mu loop (Figure 28A and Figure 
31B), which disrupts Y6 in the active site, a residue that is essential for efficient catalysis 
(Thompson et al., 2006). The stabilising quaternary structure of the dimer is also required for 
the formation of a complete active site in each subunit, because of the proximity of the 
subunit interface to the active site. If the subunit interface is disrupted, Q71, S72 and D105 
cannot form hydrogen bonds with GSH from the opposite subunit (Ji et al., 1992; Wilce and 
Parker, 1994), and the protein cannot catalyse the nucleophilic attack on non-polar xenobiotic 
compounds (see section 1.4.2). Therefore, the loss in specific activity of the mutant monomer 
(Figure 11) is due to the destabilisation of the active site, in accordance with studies 
conducted on other GST subunit interface variants (Alves et al., 2006; Hornby et al., 2002; 
Sayed et al., 2000; Thompson et al., 2006).  
The loss of quaternary structure in a protein may result in structure modifications, such as a 
reduction in the α-helical content of a protein (Hennessey et al., 1982; Woody, 1995). 
However, spectroscopic studies reveal that there are no major differences in the secondary 
(Figure 9) and tertiary (Figure 10) structures of the WT dimer and the mutant monomer. In 
fact, pulsed-labelling HDX-MS data show that the subunit of the native WT dimer  
(Figure 31A) is conformationally comparable to the native structure of the mutant monomer 
(Figure 31B). The difference in intensity of the fluorescence spectra obtained for WT dimer 
and mutant monomer could be a result of an increase in the dynamics of domain 1. The W7 
and W45 residues in domain 1 are located at the active site (nearby the mu loop), whereas 
W146 and W214 remain more buried in the hydrophobic core of domain 2  
(Figure 2A and 2B). The increased dynamics of the regions surrounding the mu loop in the 
absence of quaternary structure (Figure 31B), therefore, explain the increase in the intensity 
of the mutant monomer fluorescence spectra (Figure 10), because a more mobile environment 
can change the local quenching chemical environment and result in a higher quantum yield 








Figure 31: Conformational stability of native WT dimer and native mutant monomer 
The percentage deuteration of the tertiary structures of (A) native WT dimer and (B) native 
mutant monomer indicates that α2 becomes highly dynamic in the absence of stabilising 
quaternary structure (PDB file 1GTU). A comparison between the differences in percentage 
deuteration (C) and relative solvent accessibility (RSA) between WT dimer and mutant 
monomer at 0 M urea indicate that even though the dimer interface has been disrupted in the 





The percentage deuteration of a peptide gives an indication of how dynamic the region is, 
because regions that are highly dynamic will show a high percentage deuteration (Bai et al., 
1993; Deng et al., 1999; Loftus et al., 1986; Zhang et al., 1996). Continuous labelling HDX-
MS experiments performed on the native F56S/R81A variant of rGST M1-1 indicate that β2, 
α2, β3 and β4 in domain 1 are highly dynamic (Thompson et al., 2006). The most apparent 
difference in the levels of deuteration between native WT dimer and mutant monomer occurs 
in domain 1 (residues 22-79), indicating that like the rGST M1-1 monomeric variant, the 
human mutant monomer shows an increase in the dynamics of domain 1 structures (Figure 
28A). The highly deuterated mutant monomer residues 22-79 include the F56 key residue and 
the mu loop, located between β2 and α2 (Figure 31A, 31B and 31C), confirming previous 
findings that in the absence of quaternary structure the regions surrounding the mu loop 
become highly dynamic (Hearne and Colman, 2006; Thompson et al., 2006). The R81 
residue forms part of the mixed charge cluster at the dimer interface (Figure 2B). Disruption 
of the mixed charge cluster increases the relative solvent accessibility (RSA) at the subunit 
interface (Figure 31D), and results in an increase in the percentage deuteration of β3, β4, α3 
and α4 in the mutant monomer (Figure 31C). The dynamics of domain 1, and the solvent 
accessible surface of the dimer interface, are altered in the monomeric mutant; however, 
domain 2 remains relatively unchanged (Figure 31). 
Therefore, in the absence of stabilising quaternary structure, the regions surrounding the mu 
loop become more dynamic (Figure 28A and Figure 31) and the dimer interface becomes 
more solvent-exposed. However, the global secondary (Figure 9) and tertiary (Figure 10) 
structure of the mutant monomer remain relatively unchanged. Therefore, the mutant 










4.2. Unfolding proceeds via two stable equilibrium intermediates  
The unfolding pathway of WT dimer hGST M1a-1a must begin with the native, folded dimer 
(N2) and end with two denatured monomers (2D), and most likely proceeds via either a 
monomeric (M), or a dimeric (I2) intermediate. The equilibrium unfolding of oligomeric 
proteins is protein-concentration dependent because of the law of mass action (Jaenicke, 
1991; Neet and Timm, 1994; Ragone, 2000). The protein-concentration dependence of  
WT dimer unfolding during event 1 indicates that the dimer dissociates to form two 
monomeric intermediates (MWT) during this event (Figure 15A and 15B). WT dimer 
unfolding, using ANS binding as a probe, provides further evidence for the formation of MWT 
during unfolding event 1 (Figure 16A and 16C). ANS is an anionic dye that has been shown 
to bind to the hydrophobic H-site of numerous native GSTs (Erhardt and Dirr, 1995; Sayed et 
al., 2000; Sluis-Cremer et al., 1996; Stevens et al., 1998), including class Mu GSTs (Hornby 
et al., 2000; Kinsley et al., 2008). The increase in ANS binding during event 1 indicates that 
there is an increase in the exposure of hydrophobic surface that was previously buried at the 
subunit interface (Figure 16C), which is consistent with the formation of a monomeric 
intermediate. Additionally, SE-HPLC data show that an intermediate, which has a smaller 
mass than native dimer, appears at approximately 4 M urea (Figure 17D and 17E). Therefore, 
it can be concluded that during unfolding event 1, at approximately 4 M urea, the  
inter-subunit interactions that govern dimer stabilisation are disrupted, and WT dimer 
dissociates to form MWT. The finding is in accordance with equilibrium unfolding studies 
conducted on rGST M1-1, which indicate that a ~20 kDa monomeric intermediate is present 
in the three-state unfolding of rGST M1-1 (Hornby et al., 2000; Luo et al., 2002; Thompson 
et al., 2006). It is challenging to characterise MWT, formed during unfolding event 1, because 
the intermediate cannot be separated from the other equilibrium unfolding species (Figure 
17E and 17F).   
Structural characterisation of the mutant monomer revealed that the tertiary structure of the 
native mutant monomer is comparable to the WT dimer subunit (see section 4.1). The 
unfolding pathway of the mutant monomer must begin with a native, folded monomer 
(MMutant) and end with denatured monomer (D). Therefore, elucidation of the equilibrium 
unfolding pathway of mutant monomer provides insight into the characteristics and unfolding 
trajectory of MWT, and provides insight into the unfolding pathway of hGST M1a-1a. 
Previously, the F56S/R81A monomeric variant of rGST M1-1 was shown to lose secondary 
and tertiary structure simultaneously via a two-state unfolding process (Thompson et al., 
2006). The folding of many small dimeric and monomeric proteins, including GSTs and 
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GST-like proteins, has been shown to be a two-state process (Erhardt and Dirr, 1995; 
Gildenhuys et al., 2008; Gloss and Matthews, 1998; Kaplan et al., 1997; Wallace et al., 
1998b).  
Mutant monomer unfolding appears to be two-state when monitored using far-UV CD 
(Figure 14C). However, secondary structural changes can occur in a diffuse manner during 
unfolding (Malhotra and Udgaonkar, 2016b), and it is well known that two-state unfolding 
can be more complex than it appears, depending on the probe that is used (Pace, 1990; Zaidi 
et al., 1997). HDX-MS studies show that peptides 11-19 (residues 80-140) become 
deuterated in 4 M urea in the absence of quaternary structure (Figure 28C), indicating that α3, 
α4 and α5 do not unfold in urea concentrations below 4 M (event 1). Additionally, peptides 
20-26 (residues 141-200) only become deuterated in 8 M urea (Figure 28F), indicating that 
α6 and α7 are not altered during unfolding event 1 from 0 M to 4.5 M urea. Therefore, 
unfolding monitored using far-UV CD appears two-state for the mutant monomer because 
ellipticity at 222 nm monitors the α-helical content of a protein, and the majority of the  
α-helices only begin to unfold in urea concentrations above 4 M in a diffuse manner. Mutant 
monomer unfolding was also assessed using intrinsic fluorescence, and this probe indicates 
that unfolding does not occur via a two-state mechanism (Figure 14A and 14B). Residue 
W214 is located in the C-terminal loop (Figure 31A and 31B), and it is not a good probe to 
monitor structural events because the highly dynamic region is predominantly solvent 
exposed, even in the native state (peptide 30 Figure 28). However, the other three tryptophan 
found within the protein subunit do serve as good probes for structural events. W7 and W45 
are located at the active site, near the mu loop and monitor unfolding events in domain 1 
(Figure 31A and 31B), whereas W146 is located in the loop region between α5 and α6, and 
inserts in to the region between α6 and α7, thereby monitoring unfolding events occurring in 
domain 2 (Figure 31A and 31B). The gradual and non-cooperative transition observed for 
mutant monomer in unfolding event 1 (Figure 14A) is a result of the minor conformational 
changes that occur in the regions surrounding the dynamic mu loop in the absence of 
quaternary structure, as detected by W7 and W45. Therefore, the minor conformational 
changes that occur in the mutant monomer at low concentrations of urea show that the mutant 
monomer loses structure gradually during unfolding event 1 (Figure 14A) to form a  




WT dimer dissociates to form the monomeric MWT during unfolding event 1. WT dimer has a 
higher ∆G(H2O)1 than mutant monomer (Table 1), which indicates that the WT dimer is more 
conformationally stable. However, a greater difference between the ∆G(H2O)1 was expected 
because of the stabilising quaternary structure of the WT dimer. Dimer dissociation is highly 
cooperative and results in a large exposure of surface area, as indicated by the greater m1-
value obtained for WT dimer unfolding when compared with the m1-value of mutant 
monomer (Table 1). The lower m1-value obtained for mutant monomer unfolding suggests 
that only minor structural changes occur during unfolding event 1, and that the native 
monomer becomes more loosely packed at urea concentrations between 0 M and 4 M.  The 
mechanisms employed, and the energy barriers that must be overcome in unfolding event 1 
differ between the two proteins; however, the structural characteristics of MWT and mutant 
monomer in approximately 4 M to 5 M urea are similar.  
Hydrophobicity was assessed by monitoring unfolding using ANS binding as a probe. At 5 M 
urea, both proteins bind ANS to produce spectra with the same characteristics (Figure 16A 
and 16B), and MWT and MMutant show equal relative ANS binding (Figure 16C), proving that 
MWT and MMutant are equally hydrophobic (Figure 16A and 16B). MWT and MMutant also have 
the same hydrodynamic size (Figure 18) and the same hydrodynamic diameter, as measured 
by DLS (Figure 19A and 19B), at 5 M urea. Finally, HDX-MS data show that WT dimer and 
mutant monomer are equally deuterated at 5 M urea, indicating that the equilibrium states 
that are populated at 5 M urea are conformationally similar (Figure 28D). Therefore, MMutant 
can be used to deconvolute the unfolding of hGST M1a-1a because MWT and MMutant 
(referred to as M from this point forward) are structurally similar.  
It is not unusual for stable monomeric intermediates to populate the unfolding pathway of 
GST proteins. A structured, stable intermediate has been observed for a GST from  
Proteus mirabilius (Sacchetta et al., 1993), and bbGST P1-1 from Bufo bufo embryos unfolds 
via partially structured monomeric intermediates (Sacchetta et al., 1999). Additionally, rGST 
M1-1 unfolds via a stable, monomeric intermediate (Hornby et al., 2000). However, GST 
proteins have also been shown to unfold via more than one stable intermediate (Stevens et al., 
1998). The equilibrium unfolding data for WT dimer and mutant monomer provide evidence 
for a second equilibrium intermediate, in addition to the monomeric M intermediate formed 
on the urea-induced equilibrium unfolding pathway of hGST M1a-1a. The WT dimer 
displays protein-concentration dependence for both unfolding event 1 and 2 (Figure 15A and 
15B). Monomeric proteins show no dependence upon protein concentration during two-state 
unfolding because these molecules are unimolecular and do not undergo bimolecular events 
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(Ragone, 2000); however, the mutant monomer shows protein-concentration dependence for 
unfolding event 2 (Figure 15C and 15D). Therefore, a protein-concentration dependent event 
occurs subsequent to the formation of M, indicating that a second multi-molecular 
intermediate populates the unfolding pathway of hGST M1a-1a. The oligomeric intermediate 
(I) formed by WT dimer and mutant monomer have the same hydrodynamic volume, a 
volume that is even greater than that of the denatured proteins (Figure 18). SE-HPLC data 
also show that oligomeric I is present at the same urea concentrations as M, the monomeric 
intermediate: at 4.5 M and at 5 M urea for WT dimer (Figure 17E and 17F) and from 3 M to 
5 M urea for mutant monomer (Figure 17L-O). However, unlike dimer dissociation (event 1), 
the unfolding curves of WT dimer and mutant monomer are superimposable for unfolding 
event 2 (Figure 14 and Figure 16C). The ∆G(H2O)2 of WT dimer is only 0.7 kcal.mol
-1
 
greater than the ∆G(H2O)2 of mutant monomer. The small difference indicates that 
oligomeric I is equally stable for both WT dimer and mutant monomer. Event 2 is also 
equally cooperative for both WT dimer and mutant monomer because the m2-values are 
approximately equal (Table 1). Therefore, the event(s) occurring from 5 M to 8 M urea are 
the same for WT dimer and mutant monomer.  
It is possible that I forms as a result of insoluble aggregates; however, this is unlikely because 
unfolding is reversible (Figure 12), and refolding curves for both the WT dimer and mutant 
monomer are superimposable with the unfolding curves of each respective protein (Figure 
13). Additionally, the Rayleigh scattering at 390 nm shows no significant increase in 
scattering (Figure 16D), and absorbance spectra of protein samples unfolded in various 
concentrations of urea also show no increase in absorbance at 340 nm (Figure 19C). 
Therefore, it is more likely that oligomeric I forms as a result of the association of 
monomeric M, and that I is a stable intermediate and not an insoluble aggregate.  
The formation of two stable equilibrium intermediates may result in a difference between the 
experimental and theoretical m-values, because when the m-value is obtained through 
analysis of a complex process, an underestimation of the m-value can be observed (Soulages, 
1998). The m-value has been shown to correlate with the change in solvent accessible surface 
area (ΔASA), making it possible to calculate a theoretical m-value using the ΔASA (Myers et 
al., 1995). The ΔASA for WT dimer is 40013 Å2 and the theoretical m-value using urea as a 




. The theoretical m-value is nearly double the experimental  




(Table 1). The difference between the experimental and 









(Hornby et al., 2000). The 
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ΔASA for mutant monomer is 19553 Å2 and the theoretical m-value is 2.5 kcal.mol-1.M-1, and 




. The mtotal-value is in accordance 




value reported for the 
F56S/R81A monomeric double mutant (Thompson et al., 2006). Therefore, it is possible that 
WT dimer m1-value (Table 1) is underestimated as a result of  the formation of the 
monomeric intermediate (dimer dissociation), and not as a result of the formation of the 
oligomeric intermediate.   
The 13.5 ± 0.9 kcal.mol
-1 ∆G(H2O)total value for WT dimer falls below the  
19.8–26.8 kcal.mol-1 range obtained for other dimeric GSTs (Erhardt and Dirr, 1995; Kaplan 
et al., 1997; Wallace et al., 1998b) and below the 19.8 kcal.mol
-1
 obtained for rGST M1-1 
(Hornby et al., 2000). The reduced ∆G(H2O)total could be a result of an inappropriate fitting 
model, or as a result of overparameterisation, which results in an underestimated ∆G(H2O)1 
for the dimer dissociation event. Conversely, the 11.3 ± 0.7 kcal.mol
-1
 ∆G(H2O)total value 
obtained for mutant monomer is within the 6-14 kcal.mol
-1
 range stated for monomeric 
proteins (Neet and Timm, 1994), and compares well with the 10.1 kcal.mol
-1
 obtained for the 
monomeric F56S/R81A rGST M1-1 mutant (Thompson et al., 2006).  
The change in Gibbs free energy in the absence of urea (∆G(H2O)total) will be affected by 
intermediate formation because the ∆G(H2O)total gives an indication of the conformational 
stability of a protein (Pace, 1986). Therefore, the underestimation of ∆G(H2O)1 could be a 
result of the formation of M. Regardless of the underestimation of ∆G(H2O)1, the  
∆G(H2O)total value of the mutant monomer is lower than that of the WT dimer. The reduced 
∆G(H2O)total value of the mutant monomer indicates that the native state of the mutant 
monomer is less stable than the native state of the WT dimer. Additionally, the reduced 
∆G(H2O)total value is a result of the reduced ∆G(H2O)1 value, and not as a result of the 
∆G(H2O)2 value. The conclusion is supported by the fact that the Cm value obtained for 
unfolding event 1 (Cm1) is lower for mutant monomer (3 M) than for WT dimer (3.8 M) 
whereas the Cm value obtained for unfolding event 2 (Cm2) is the same (6 M) for both proteins 
(Table 1).  
Analysis of the Cm values obtained for each peptide from the HDX-MS data reveal that 
unfolding occurs cooperatively, based on the stability of different regions in hGST M1a-1a 
(Figure 30B and 30C). A lower Cm value indicates that the peptide is unfolding at a lower 
urea concentration, and is less susceptible to denaturation by urea. A higher Cm value 
indicates that the peptide unfolds at a higher urea concentration, and is more stable (Pan et 
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al., 2004). Figure 30 C indicates that the least stable key group peptides have a smaller 
fraction unfolded than the medium stable key group between 4 M and 6 M urea. The 
unexpected result could be due to aggregation of the mutant monomer at the high initial 
concentrations of protein required to conduct successful HDX-MS studies. Additionally, the 
mutant monomer begins to destabilise in 2 M urea (Figure 17 K) and at 3 M urea the 
oligomeric intermediate has already formed (Figure 17 L). Therefore, at urea concentrations 
between 4 M and 6 M, the monomeric intermediate (M) forms the oligomeric intermediate 
(I). The formation of I will result in a decrease in the percent deuteration, which will result in 
a decrease in the fraction of unfolded protein. The fraction of unfolded protein in each group 
reveals that the lock-and-key motif, as well as the structural elements surrounding the mu 
loop (domain1), are destabilised before the mixed-charge cluster at the subunit interface 
(domain 2) (Figure 30). It can be concluded that dimer dissociation requires the 
destabilisation of domain 1 interface structures (β2, α2, β3, β4 and part of α3) but that it is the 
destabilisation of α3 and domain 2 interface structures (α4 and α5) that results in complete 
dimer dissociation and the progression of the unfolding reaction.  
In the EX1 limit, amide sites that are involved in a cooperative unfolding event will result in 
bimodal distributions in the mass spectra for that peptide at a specific urea concentration 
(Malhotra and Udgaonkar, 2015). These bimodal distributions will likely show two distinct 
peaks whose masses will reflect the undeuterated and the fully deuterated sites (Deng and 
Smith, 1999; Pan and Smith, 2004). Peptides within the highly unstable key group (Figure 
24) and the medium stable charged cluster group (Figure 25 and Figure 26) display bimodal 
distributions in urea concentrations between 4 M and 8 M, which suggests that unfolding in 
these regions is cooperative. Additionally, analysis of the bimodality of the mass spectra 
indicates that the heavy peak at 5 M and 6 M are more deuterated than the denatured 8 M 
peak for both WT dimer and mutant monomer (Figure 24-26). The more heavily deuterated 
peak could indicate that subunit interface residues are involved in the formation of the 
exposed hydrophobic monomeric intermediates with numerous exposed residues, because an 
oligomeric intermediate would be shielded and show a lower mass to charge ratio (m/z) than 
a monomeric or denatured sample. The peptide data indicate that there is a high degree of 
interdomain cooperativity between domain 1 and domain 2, and that the two domains unfold 
in a concerted manner rather than independently, in accordance with studies performed on 




The unfolding of hGST M1a-1a results in denatured protein that maintains partial residual 
structures. Residual structure can refer to native-like structural elements that guide the protein 
to the native state during refolding or simply to the non-native protection of solvent 
accessible surface area (Daggett and Fersht, 2003). The far-UV CD (Figure 20) and intrinsic 
tryptophan data (Figure 21) suggest that the denatured state at 8 M urea shows no residual 
tertiary or secondary structure. However, hGST M1a-1a is still able to bind ANS in 8 M urea, 
which indicates that residual structures are present (Figure 16). The residual structures of 
denatured states are often contained within the hydrophobic core of the protein 
(Hammarström and Jonsson, 2005). Domain 2 is defined as the hydrophobic core of GST 
class Mu (Ji et al., 1992); however, the HDX-MS data presented in this study suggests that 
the highly stable core group is composed of  α6 and α7, and that these helices are 
predominantly responsible for maintaining the stable core of the protein (Figure 28F and 
Figure 30). At 8 M urea peptides 10 (Figure 24), 14 (Figure 25) and 18 (Figure 26) are not 
fully deuterated, indicating that the denatured state is more shielded than the heavy peak at  
5 M and 6 M. It is important to note that the residual structure of the denatured state could be 
as minimal as the protection of solvent accessible surface area in α6 and α7. However, the 
possibility that at 8 M both WT dimer and mutant monomer are not fully unfolded, as a result 
of the formation of oligomeric I (Figure 24B and Figure 25B), cannot be ignored.   
The stability of the core structures of hGST M1a-1a, even in the absence of stabilising 
subunit interactions (Figure 28 and Figure 30), indicates that intersubunit interactions have 
evolved more recently and that ancestral GSTs were likely monomeric, which is in 
accordance with the hypothesis that canonical GSTs have evolved from monomeric enzymes 
like glutaredoxin 2 (Ladner et al., 2004; Sheehan et al., 2001). It is probable that the ancestral 
GSTs evolved to incorporate slightly varied intersubunit interactions between classes so that 
the biological function of GSTs could be increase by expanding the substrate specificity 








4.3. Proposed equilibrium unfolding pathway of hGST M1a-1a 
The data obtained from the in-depth comparative study on the equilibrium unfolding of  
WT dimer and the F56S/R81A mutant monomer has elucidated following proposed unfolding 
pathway for monomeric hGST M1a: 
M   ↔   I   ↔   D       (Scheme 1) 
where M is the native F56S/R81A mutant monomer, I is an oligomeric equilibrium 
intermediate and D is the denatured state.  
Additionally, the following equilibrium unfolding pathway for WT dimer hGST M1a-1a has 
been proposed: 
N2   ↔   2M   ↔   2I   ↔   2D    (Scheme 2) 
where N2 is the native dimer, M is a monomeric equilibrium intermediate, I is an oligomeric 
equilibrium intermediate and D is the denatured state.  
The four-state equilibrium unfolding mechanism of hGST M1a-1a (Scheme 2) is in contrast 
with the two-state mechanism reported for class Alpha and class Pi GSTs (Erhardt and Dirr, 
1995; Gildenhuys et al., 2010; Kaplan et al., 1997; Wallace et al., 1998b) and the three-state 
mechanism reported for dimeric rGST M1-1 (Hornby et al., 2000), bbGST P1-1 (Sacchetta et 
al., 1999) and Physa acuta GST3 (Abdalla and Hamed, 2006). The Sigma class also unfolds 
via a four-state mechanism, but unlike hGST M1a-1a, the oligomeric (dimeric) intermediate 
forms before the monomeric intermediate (Stevens et al., 1998). A monomeric intermediate 
is also formed along the equilibrium unfolding pathway of rGST M1-1 and rGST M2-2, but 
no other intermediate states are observed for class Mu GST isolated from rat (Hornby et al., 
2000).  
The differences observed in the equilibrium unfolding mechanisms of rGST M1-1 and  
hGST M1a-1a indicates that even minor differences in the primary structure of a protein can 
have an impact on the stability of the structural elements of the protein (Figure 3). It is not 
unheard of for minor differences in the primary structure within a class to cause significant 
differences in the equilibrium unfolding mechanism. An intermediate species that is stabilised 
in the equilibrium unfolding pathway of the GST class Pi isoenzyme isolated from the  
Bufo bufo embryo (bbGST P1-1) (Sacchetta et al., 1999) is not detected in the unfolding 
pathway of class Pi GST isolated from pig (Erhardt and Dirr, 1995) or human (Gildenhuys et 
al., 2010).  
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Differences in the conformational stability between isoenzymes within the rat GST Mu have 
also been reported (Hornby et al., 2000). The rGST M1-1 and rGST M2-2 isoenzymes have a 
78 % sequence similarity, but M1-1 was shown to have a weaker quaternary structure and a 
more stable monomeric intermediate than M2-2 (Hornby et al., 2000; Hussey and Hayes, 
1993; Luo et al., 2002). Similarly, there is a 79 % similarity in sequence identity between 
hGST M1a-1a and rGST M1-1, with the majority of the differences occurring at the subunit 
interface. These differences could result in the altered properties of the monomeric 
intermediates formed by hGST M1a-1, when compared with the rGST M1-1 monomeric 
intermediate.  
HDX-MS studies conducted on rGST M1-1 also show that α4 and α5 form a structural motif 
of stability in domain 2, which is only disrupted once domain 1 has become destabilised 
(Thompson et al., 2006). However, the monomeric intermediate of rGST M1-1 does not 
associate to form an additional oligomeric intermediate. The 21 % difference in sequence 
similarity could result in the formation of a monomeric intermediate that is more stable than 
the M formed when hGST M1a-1a dissociates. The difference could arise from the fact that 
once the dimer has dissociated, the stability and conformation of α1 in domain 1 of  
rGST M1-1 remains relatively unchanged (Thompson et al., 2006), whereas α1 of  
hGST M1a-1a becomes highly dynamic after dimer dissociation. Additionally, in  
hGST M1a-1a a C77 is present at the subunit interface, whereas in rGST M1-1 the residue is 
a conserved R77 (Figure 3) (Section 1.4.3). The R77 in domain 1 of rGST M1-1 forms an 
interdomain salt-bridge with D97 and E100 of domain 2 (Ji et al., 1992), whereas the C77 in 
domain 1 of hGST M1a-1a is not able to form stabilising interdomain interaction  
(Figure 2B ). Therefore, the monomeric intermediate (M) formed when hGST M1a-1a 
dissociates lacks the stabilising interdomain interaction that is present in the monomeric 
intermediate formed by rGST M1-1, which could account for the non-native association of M 








The equilibrium unfolding of hGST M1a-1a is four-state. The dissociation of N2 to form 
monomeric M requires the destabilisation of structural elements in both domain 1 and  
domain 2. Destabilisation of the lock-and-key motif, as well as the structures surrounding the 
mu loop, results in a destabilisation of domain 1. The destabilisation of domain 1 results in 
destabilisation of α4 and α5 in domain 2, because the domains unfold in a concerted manner. 
Dimer dissociation results in the formation of a loosely-packed and hydrophobic monomeric 
equilibrium intermediate, with compromised short-range contacts (M). The compromised M 
self-associates to form a bulky, shielded oligomeric equilibrium intermediate, I. Finally, the 
destabilisation of α6 and α7 in the hydrophobic core of domain 2, results in further 
denaturation of hGST M1a-1a. The denatured state (D) is not fully unfolded, and minor 
residual structural elements are suspected to persist. 
The equilibrium unfolding pathway proposed at this stage describes the stable equilibrium 
intermediates formed along the urea denaturation axis satisfactorily. In order to attain more 
reliable thermodynamic parameters for the WT dimer, complex and rigorous fitting models, 
which are able to fit the complete 4-state WT dimer unfolding, will have to be developed. 
Additionally, unfolding kinetics studies will be undertaken to obtain a more comprehensive 
understanding of the unfolding mechanism. An initial conditions test and double-jump 
unfolding experiments will clarify whether the unfolding pathway of hGST M1a-1a is 
sequential or parallel, and whether denaturation of I is the rate-limiting step. Chemical 
unfolding is a dynamic, multistate process with the coexistence of numerous conformations 
(Seelig, 2018). It will, therefore, also be useful to study the unfolding pathway of  
hGST M1a-1a using other denaturants, such as guanidinium chloride, pH and pressure to 
provide further details about cooperativity and the energy barriers to unfolding. Investigation 
into these characteristics will provide a more complete understanding of the structural basis 
of hGST M1a-1a unfolding, and provide novel insights into the mechanisms of protein 
(un)folding.  
The field of protein (un)folding is constantly being critically re-examined and the established 
views of protein (un)folding are thoroughly questioned, tested and challenged (Arai, 2018; 
Lapidus, 2017; Žoldák et al., 2017). Researchers are constantly working at defining 
additional parameters that can be used to describe protein (un)folding (Hall et al., 2018), and 
it is important that we continue to add to the knowledge base of one of most pertinent 
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APPENDIX Table A: Percentage recovery of the WT dimer and F56S/R81A mutant 
monomer 
Ellipticity at 222 nm 
 Native protein Refolded protein % Recovery 
WT dimer - 511.7 - 510.6 99.8 
Mutant monomer - 461.3 - 453.3 98.3 
Fluorescence intensity at 340 nm 
 Native protein Refolded protein % Recovery 
WT dimer 200.2 209.1 104.4 



















APPENDIX Figure A: Peptide heat map for the WT dimer 
The peptides (green and yellow) were analysed using HD Examiner 1.3 (Sierra Analytics, LLC, Modesto,CA). Each peptide is mapped to the 
corresponding amino acid sequence that it covers. The percentage deuteration at various urea concentrations is coloured according to the key (insert). 
The thrombin cleavage site results in the addition of two amino acids (glycine and serine) at the N-terminus of the protein. These two amino acids 






APPENDIX Figure B: Peptide heat map for the mutant monomer 
The peptides (green and yellow) were analysed using HD Examiner 1.3 (Sierra Analytics, LLC, Modesto,CA). Each peptide is mapped to the 
corresponding amino acid sequence that it covers. The percentage deuteration at various urea concentrations is coloured according to the key (insert). 
The thrombin cleavage site results in the addition of two amino acids (glycine and serine) at the N-terminus of the protein. These two amino acids 
have been accounted for in the sequence and numbering.  
